<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" id="cre270103" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Clin Exp Dent Res</journal-id><journal-id journal-id-type="iso-abbrev">Clin Exp Dent Res</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)2057-4347</journal-id><journal-id journal-id-type="publisher-id">CRE2</journal-id><journal-title-group><journal-title>Clinical and Experimental Dental Research</journal-title></journal-title-group><issn pub-type="epub">2057-4347</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39988729</article-id><article-id pub-id-type="pmc">PMC11847645</article-id>
<article-id pub-id-type="doi">10.1002/cre2.70103</article-id><article-id pub-id-type="publisher-id">CRE270103</article-id><article-categories><subj-group subj-group-type="overline"><subject>Original Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Secretomes of Gingival Fibroblasts From Periodontally Diseased Tissues: A Proteomic Analysis</article-title></title-group><contrib-group><contrib id="cre270103-cr-0001" contrib-type="author"><name><surname>Smed&#x000e5;s</surname><given-names>Anne Kari</given-names></name><xref rid="cre270103-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="cre270103-cr-0002" contrib-type="author"><name><surname>Paris</surname><given-names>Lovise Gangeskar</given-names></name><xref rid="cre270103-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="cre270103-cr-0003" contrib-type="author"><name><surname>Al&#x02010;Sharabi</surname><given-names>Niyaz</given-names></name><xref rid="cre270103-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="cre270103-cr-0004" contrib-type="author"><name><surname>Kristoffersen</surname><given-names>Einar K.</given-names></name><xref rid="cre270103-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="cre270103-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="cre270103-cr-0005" contrib-type="author"><name><surname>Sanz</surname><given-names>Mariano</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-6293-5755</contrib-id><xref rid="cre270103-aff-0004" ref-type="aff">
<sup>4</sup>
</xref><xref rid="cre270103-aff-0005" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib id="cre270103-cr-0006" contrib-type="author"><name><surname>Mustafa</surname><given-names>Kamal</given-names></name><xref rid="cre270103-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="cre270103-cr-0007" contrib-type="author"><name><surname>Bun&#x000e6;s</surname><given-names>Dagmar Foss&#x000e5;</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-8592-7467</contrib-id><xref rid="cre270103-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="cre270103-cr-0008" contrib-type="author" corresp="yes"><name><surname>Shanbhag</surname><given-names>Siddharth</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-0056-8379</contrib-id><xref rid="cre270103-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cre270103-aff-0002" ref-type="aff">
<sup>2</sup>
</xref><xref rid="cre270103-aff-0005" ref-type="aff">
<sup>5</sup>
</xref><address><email>siddharth.shanbhag@uib.no</email></address></contrib></contrib-group><aff id="cre270103-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Clinical Dentistry, Faculty of Medicine</named-content>
<institution>University of Bergen</institution>
<city>Bergen</city>
<country country="NO">Norway</country>
</aff><aff id="cre270103-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Department of Immunology and Transfusion Medicine</named-content>
<institution>Haukeland University Hospital</institution>
<city>Bergen</city>
<country country="NO">Norway</country>
</aff><aff id="cre270103-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">Department of Clinical Science, Faculty of Medicine</named-content>
<institution>University of Bergen</institution>
<city>Bergen</city>
<country country="NO">Norway</country>
</aff><aff id="cre270103-aff-0004">
<label>
<sup>4</sup>
</label>
<named-content content-type="organisation-division">ETEP Research Group</named-content>
<institution>University Complutense of Madrid</institution>
<city>Madrid</city>
<country country="ES">Spain</country>
</aff><aff id="cre270103-aff-0005">
<label>
<sup>5</sup>
</label>
<named-content content-type="organisation-division">Department of Periodontology, Faculty of Dentistry</named-content>
<institution>University of Oslo</institution>
<city>Oslo</city>
<country country="NO">Norway</country>
</aff><author-notes><corresp id="correspondenceTo">
<label>*</label>
<bold>Correspondence:</bold> Siddharth Shanbhag (<email>siddharth.shanbhag@uib.no</email>)<break/>
</corresp></author-notes><pub-date pub-type="epub"><day>23</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2025</year></pub-date><volume>11</volume><issue seq="70">1</issue><issue-id pub-id-type="doi">10.1002/cre2.v11.1</issue-id><elocation-id>e70103</elocation-id><history>
<date date-type="rev-recd"><day>19</day><month>1</month><year>2025</year></date>
<date date-type="received"><day>06</day><month>12</month><year>2024</year></date>
<date date-type="accepted"><day>13</day><month>2</month><year>2025</year></date>
</history><permissions><!--&#x000a9; 2025 The Author(s). Clinical and Experimental Dental Research published by John Wiley & Sons Ltd.--><copyright-statement content-type="article-copyright">&#x000a9; 2025 The Author(s). <italic toggle="yes">Clinical and Experimental Dental Research</italic> published by John Wiley &#x00026; Sons Ltd.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="file:CRE2-11-e70103.pdf"/><abstract><title>ABSTRACT</title><sec id="cre270103-sec-0010"><title>Objective</title><p>Cell secretomes represent a promising strategy for periodontal and bone regeneration. The objective of this study was to characterize the secretome of human gingival fibroblasts (GF) from periodontally diseased tissues (GF&#x02010;perio) using proteomics.</p></sec><sec id="cre270103-sec-0020"><title>Materials and Methods</title><p>Conditioned media of GF&#x02010;perio from periodontitis patients (<italic toggle="yes">n</italic>&#x02009;=&#x02009;6, 48&#x02010;h serum&#x02010;free culture) were subjected to liquid chromatography with tandem mass spectrometry. Global profiles, differentially expressed proteins (DEPs), and functional/gene&#x02010;set enrichment (FEA) were analyzed using bioinformatics. Selected bone regeneration&#x02010;related proteins were additionally measured using a multiplex immunoassay. Conditioned media of GF from periodontally healthy subjects were used as a reference.</p></sec><sec id="cre270103-sec-0030"><title>Results</title><p>Overall, 1833 proteins were detected in GF&#x02010;perio secretomes, including several growth factors, cytokines, chemokines, and extracellular matrix proteins important for wound healing and regeneration. Key bone&#x02010;related cytokines (FGF2, MCP1, GPNMB, MMP2, IL6, IL8) were confirmed by an immunoassay. Compared to the reference group, 127 exclusive proteins and 73 DEPs (<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05) were identified in the GF&#x02010;perio group. FEA revealed significant enrichment of &#x0201c;exosome&#x0201d; and &#x0201c;cytoplasm&#x0201d; related cellular components in GF&#x02010;perio secretomes.</p></sec><sec id="cre270103-sec-0040"><title>Conclusion</title><p>The secretome of GF from periodontally diseased tissues may hold therapeutic potential, with several proteins important for wound healing and regeneration, especially those related to exosome functions.</p></sec></abstract><kwd-group><kwd id="cre270103-kwd-0001">conditioned media</kwd><kwd id="cre270103-kwd-0002">in vitro</kwd><kwd id="cre270103-kwd-0003">mass spectrometry</kwd><kwd id="cre270103-kwd-0004">periodontal disease</kwd><kwd id="cre270103-kwd-0005">periodontitis</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source><institution-wrap><institution>This work was supported by Helse Vest Research Funding, Norway (F&#x02010;12124) and &#x0201c;Stiftelsen til tannlegevitenskapens fremme,&#x0201d; Norway.
</institution><institution-id institution-id-type="doi">10.13039/501100004257</institution-id></institution-wrap></funding-source></award-group></funding-group><counts><fig-count count="2"/><table-count count="5"/><page-count count="13"/><word-count count="7325"/></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>February 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.4 mode:remove_FC converted:07.04.2025</meta-value></custom-meta></custom-meta-group></article-meta><notes><fn-group><fn id="cre270103-note-0001"><p>The first two authors contributed equally to this article.</p></fn></fn-group></notes></front><body><sec id="cre270103-sec-0050"><label>1</label><title>Introduction</title><p>Human gingival fibroblasts (GF) are a crucial component of the gingival stroma and have a significant role in the maintenance of periodontal tissue architecture and homeostasis (Wielento et al.&#x000a0;<xref rid="cre270103-bib-0051" ref-type="bibr">2023</xref>). Fibroblasts primarily synthesize the extracellular matrix (ECM), which consists of a variety of macromolecules whose assembly, architecture, and biomechanical properties vary within and between tissues (Plikus et al.&#x000a0;<xref rid="cre270103-bib-0038" ref-type="bibr">2021</xref>; McCulloch and Bordin&#x000a0;<xref rid="cre270103-bib-0032" ref-type="bibr">1991</xref>). Moreover, fibroblasts communicate with each other and with other cells by secreting growth factors and cytokines or by developing cell&#x02013;cell contacts, creating cellular communication networks (Plikus et al.&#x000a0;<xref rid="cre270103-bib-0038" ref-type="bibr">2021</xref>). While the primary function of GF is the maintenance of the homeostasis of the gingival tissues by regulating the production of ECM, these cells also play important roles in various physiological (wound healing) and pathological situations (inflammation) due to their high regeneration potential (Wielento et al.&#x000a0;<xref rid="cre270103-bib-0051" ref-type="bibr">2023</xref>; H&#x000e4;kkinen et al.&#x000a0;<xref rid="cre270103-bib-0016" ref-type="bibr">2014</xref>).</p><p>In periodontitis, periodontal tissue destruction occurs due to the combination of a dysbiotic subgingival biofilm and a non&#x02010;resolving host&#x02010;response, which results in changes in the ECM and surrounding microenvironment. This dysbiosis, in turn, activates fibroblasts through migration, proliferation, and contraction to restore homeostasis in the damaged tissue (Wielento et al.&#x000a0;<xref rid="cre270103-bib-0051" ref-type="bibr">2023</xref>). This ability to respond to chemical and physical signals from the ECM, allows the GF to adopt a secretory and migratory phenotype resulting in &#x0201c;scarless&#x0201d; tissue healing, with a regenerative potential similar to adult mesenchymal stem cells (MSC), as demonstrated both in vitro and in vivo (H&#x000e4;kkinen et al. <xref rid="cre270103-bib-0016" ref-type="bibr">2014</xref>; Kim et al.&#x000a0;<xref rid="cre270103-bib-0022" ref-type="bibr">2021</xref>). Thus, gingiva represents a minimally invasive source of cells for therapeutic applications.</p><p>Of particular interest in the context of current regenerative therapies is the paracrine activity of cells via their secretomes (Wang, Chen, et al.&#x000a0;<xref rid="cre270103-bib-0050" ref-type="bibr">2022</xref>). According to the Medical Subject Headings (MeSH) secretomes are defined as &#x0201c;the set of all the soluble factors and extracellular vesicles secreted into the extracellular space by cells.&#x0201d; Secretion of such components, including soluble proteins (growth factors, cytokines, chemokines), lipids, nucleic acids and extracellular vesicles (EV), serves fundamental functions in both the autocrine and paracrine cell signaling pathways for regulating the local microenvironment. Therefore, the use of cell secretomes, in the form of cell conditioned media (CM), may offer a promising alternative to currently complex and cost&#x02010;intensive cell therapies for advanced tissue regeneration. Practical benefits include relative ease of preparation, &#x0201c;off&#x02010;the&#x02010;shelf&#x0201d; application, and better cost&#x02010;efficacy (Marolt Presen et al.&#x000a0;<xref rid="cre270103-bib-0031" ref-type="bibr">2019</xref>). In the context of periodontal/bone regeneration, previous data suggest that CM may be at least equally, if not more, effective than cell transplantation (Hiraki et al.&#x000a0;<xref rid="cre270103-bib-0019" ref-type="bibr">2020</xref>; Osugi et al.&#x000a0;<xref rid="cre270103-bib-0035" ref-type="bibr">2012</xref>; Sanchooli et al.&#x000a0;<xref rid="cre270103-bib-0041" ref-type="bibr">2017</xref>; Shanbhag et al.&#x000a0;<xref rid="cre270103-bib-0044" ref-type="bibr">2023</xref>).</p><p>Currently, various tissue/cell sources are being investigated to produce secretomes for therapeutic applications. Clinical grade secretome production requires ex vivo cell culture and expansion, ideally under Good Manufacturing Practice (GMP) conditions. Gingival tissues can be easily obtained during periodontal surgical procedures and are often discarded as clinical waste during resective surgery, which further enhances the prospects of gingiva as a source of therapeutic cells (McCulloch and Bordin&#x000a0;<xref rid="cre270103-bib-0032" ref-type="bibr">1991</xref>). Previous studies have compared various properties of GF (Baek et al.&#x000a0;<xref rid="cre270103-bib-0003" ref-type="bibr">2013</xref>; Li et al.&#x000a0;<xref rid="cre270103-bib-0026" ref-type="bibr">2021</xref>; Kang et al.&#x000a0;<xref rid="cre270103-bib-0021" ref-type="bibr">2016</xref>; Yang et al.&#x000a0;<xref rid="cre270103-bib-0052" ref-type="bibr">2020</xref>; Bartold and Page&#x000a0;<xref rid="cre270103-bib-0006" ref-type="bibr">1986a</xref>; Kanda&#x02010;Nakamura et al.&#x000a0;<xref rid="cre270103-bib-0020" ref-type="bibr">1996</xref>; Bao et al.&#x000a0;<xref rid="cre270103-bib-0004" ref-type="bibr">2020</xref>; Bartold and Page&#x000a0;<xref rid="cre270103-bib-0007" ref-type="bibr">1986b</xref>), or gingival progenitor cells (Makkad&#x000a0;<xref rid="cre270103-bib-0030" ref-type="bibr">2023</xref>; Beki&#x00107; et al.&#x000a0;<xref rid="cre270103-bib-0008" ref-type="bibr">2022</xref>; Ge et al.&#x000a0;<xref rid="cre270103-bib-0014" ref-type="bibr">2012</xref>), isolated from healthy versus periodontitis&#x02010;affected tissues. Moreover, proteomic analyses of in situ or in vitro cultured GF from healthy (Bao et al.&#x000a0;<xref rid="cre270103-bib-0004" ref-type="bibr">2020</xref>; McKnight et al.&#x000a0;<xref rid="cre270103-bib-0033" ref-type="bibr">2014</xref>; Onyedibe et al.&#x000a0;<xref rid="cre270103-bib-0034" ref-type="bibr">2022</xref>) and diseased sites (Bao et al.&#x000a0;<xref rid="cre270103-bib-0004" ref-type="bibr">2020</xref>) have been reported. Recent data also indicates that the CM of GF has anti&#x02010;inflammatory and pro&#x02010;wound healing effects based on in vitro and in vivo assays (Ahangar et al.&#x000a0;<xref rid="cre270103-bib-0002" ref-type="bibr">2020</xref>). However, proteomic analyses of the secretomes of GF from periodontitis&#x02010;affected tissues (GF&#x02010;perio) are lacking. Given the important roles of GF in homeostasis, ECM synthesis/remodeling, immune modulation, and wound healing during both periodontal health and disease, it is reasonable to expect that the proteomic mediators of these functions would be reflected (at least to some extent) in their secretomes. Therefore, the objective of the present study was to investigate the composition of the secretomes of GF&#x02010;perio using proteomics.</p></sec><sec sec-type="materials-and-methods" id="cre270103-sec-0060"><label>2</label><title>Materials and Methods</title><sec id="cre270103-sec-0070"><label>2.1</label><title>Cell Culture</title><p>The use of human cells and tissues was approved by the Regional Committees for Medical Research Ethics in Norway (2011/1516/REK, 2016/1267/REK&#x02010;nord). GF&#x02010;perio were isolated from biopsies obtained following informed donor consent, as previously described (Shanbhag et al.&#x000a0;<xref rid="cre270103-bib-0044" ref-type="bibr">2023</xref>). Briefly, gingival connective tissues were harvested from systemically healthy nonsmoking Stage III or IV periodontitis patients (<italic toggle="yes">n</italic>&#x02009;=&#x02009;6; 46&#x02013;72 years) undergoing access flap surgery at the Department of Clinical Dentistry, University of Bergen, Bergen, Norway. All patients fulfilled the criteria for surgical intervention, that is, not fulfilling the therapeutic endpoints after subgingival instrumentation and adequate plaque control (periodontal therapy steps 1 and 2), as reflected by probing pocket depth (PPD)&#x02009;&#x0003e;&#x02009;5&#x02009;mm and bleeding on probing (BoP), that is, <italic toggle="yes">persistent inflammation</italic>, despite previous nonsurgical therapy and adequate plaque control (Sanz et al.&#x000a0;<xref rid="cre270103-bib-0042" ref-type="bibr">2020</xref>). One connective tissue biopsy per patient was harvested from the interdental aspect of a full&#x02010;thickness mucoperiosteal flap around maxillary or mandibular first or second molars. The tissue biopsy was placed in a tube containing phosphate&#x02010;buffered saline (PBS; Invitrogen, Waltham, MA, USA) and immediately transferred to the laboratory for processing. After thorough washing (3&#x000d7;) with PBS, primary explant cultures of GF&#x02010;perio were established in Dulbecco's Modified Eagle's medium (DMEM, Invitrogen, Carlsbad, CA, USA) supplemented with 10% fetal bovine serum (GE Healthcare, South Logan, UT, USA) and 1% antibiotics (penicillin/streptomycin; GE Healthcare). Cells were sub&#x02010;cultured and expanded in humidified 5% CO<sub>2</sub> at 37&#x000b0;C. Passage&#x02010;2 or &#x02010;3 cells from each of the donors were used to prepare CM (Shanbhag et al.&#x000a0;<xref rid="cre270103-bib-0044" ref-type="bibr">2023</xref>) (Figure&#x000a0;<xref rid="cre270103-suppl-0001" ref-type="supplementary-material">S1</xref>). As a reference group for the proteomic analysis, CM was prepared from GF (passage&#x02010;2 or &#x02010;3) of periodontally healthy subjects (n&#x02009;=&#x02009;6; GF&#x02010;healthy) obtained from a biobank at the Department of Clinical Dentistry, University of Bergen. These cells were obtained during routine dental procedures from clinically healthy and non&#x02010;inflamed gingival tissue sites and cryopreserved for general research use (not specifically for the present study).</p></sec><sec id="cre270103-sec-0080"><label>2.2</label><title>Preparation of CM</title><p>CM from GF&#x02010;perio and GF&#x02010;healthy were prepared using a standardized protocol (Shanbhag et al.&#x000a0;<xref rid="cre270103-bib-0044" ref-type="bibr">2023</xref>). Briefly, passage&#x02010;2 or &#x02010;3 cells from each donor were separately cultured in growth media until 80% confluency at which point the media was removed and, following 3&#x000d7; washes with PBS (Invitrogen, Waltham, MA, USA), replaced with serum&#x02010; and antibiotic&#x02010;free DMEM. After 48&#x02009;h, the supernatant media (CM) were collected, centrifuged (4000<italic toggle="yes">g</italic>, 10&#x02009;min), aliquoted, and stored at &#x02212;80&#x000b0;C until further use. Before experiments, the CM were concentrated (~30 fold) using Amicon Ultra&#x02010;15 3&#x02009;kDa centrifugal filter devices (Merck Millipore, Billerica, MA, USA) following the manufacturer's protocol. Briefly, after PBS equilibration, 15&#x02009;mL of each CM was centrifuged in the Ultra&#x02010;15 tubes at 4000<italic toggle="yes">g</italic> for 30&#x02009;min at 4&#x000b0;C, followed by buffer exchange with PBS and re&#x02010;centrifugation at 4000<italic toggle="yes">g</italic> for 30&#x02009;min at 4&#x000b0;C. The corresponding concentrated CM from the individual donors were used for proteomic analysis.</p></sec><sec id="cre270103-sec-0090"><label>2.3</label><title>Liquid Chromatography With Tandem Mass Spectrometry (LC&#x02010;MS/MS)</title><p>CM from GF&#x02010;perio and GF&#x02010;healthy were analyzed using LC&#x02010;MS/MS via label&#x02010;free quantitation, as previously described (Aaseb&#x000f8; et al.&#x000a0;<xref rid="cre270103-bib-0001" ref-type="bibr">2021</xref>). Briefly, total protein concentration of each sample was measured using bioinchonic acid assay (Pierce BCA Kit, Thermo Fisher, Waltham, MA, USA) and 10&#x02009;&#x003bc;g protein was processed to obtain tryptic peptides. About 0.5&#x02009;&#x003bc;g protein, as tryptic peptides dissolved in 2% acetonitrile and 0.5% formic acid, was injected into an Ultimate 3000 RSLC system connected online to an Exploris 480 mass spectrometer equipped with EASY&#x02010;spray nano&#x02010;electrospray ion source (all from Thermo Scientific, Sunnyvale, CA, USA). Additional details of LC&#x02010;MS/MS are reported in the&#x000a0;<xref rid="cre270103-suppl-0001" ref-type="supplementary-material">Supporting information</xref>. The LC&#x02010;MS/MS data have been deposited to the Proteome&#x02010;Xchange Consortium via the PRIDE partner repository (<ext-link xlink:href="https://www.ebi.ac.uk/pride/" ext-link-type="uri">https://www.ebi.ac.uk/pride/</ext-link>; accessed on 07.08.2024) with the data set identifier PXD054664.</p></sec><sec id="cre270103-sec-0100"><label>2.4</label><title>Bioinformatic Analysis</title><p>The LC&#x02010;MS/MS raw files were searched using Proteome Discoverer software (version 2.5.0.400; Thermo Scientific) against the human database. Data were analyzed using Perseus software (version 2.0.9.0) (Tyanova et al.&#x000a0;<xref rid="cre270103-bib-0047" ref-type="bibr">2016</xref>). To ensure accurate quantification of proteins, a filtration strategy based on detection of proteins in at least five (of six) donors in each CM group (GF&#x02010;perio and GF&#x02010;healthy) was applied. First, common (proteins identified in both groups) and exclusive proteins (proteins identified in only the perio or healthy group) were identified. Next, quantitative analysis of the common proteins was performed to identify the differentially expressed proteins (DEPs) using a two&#x02010;sided Student's <italic toggle="yes">t</italic>&#x02010;test [&#x02212;log10(<italic toggle="yes">p</italic>&#x02010;value) and <italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05] in combination with a permutation&#x02010;based correction for multiple hypothesis testing (false discovery rate; FDR&#x02009;=&#x02009;0.05). Functional profiling of common proteins between the groups and exclusive proteins in each group was performed using the g: Profiler software (version e111_eg58_p18_30541362) (Kolberg et al.&#x000a0;<xref rid="cre270103-bib-0023" ref-type="bibr">2023</xref>) based on the gene ontology (GO) categories of molecular function (MF), biological process (BP), and cellular component (CC) databases. Additional details of the bioinformatic analysis are reported in the&#x000a0;<xref rid="cre270103-suppl-0001" ref-type="supplementary-material">Supporting information</xref>. Functional enrichment analysis (FEA) was performed to classify individual proteins into similar functional categories (MP, BP, CC) using the open&#x02010;access functional enrichment analysis tool &#x02013; FunRich, as previously described (Pathan et al.&#x000a0;<xref rid="cre270103-bib-0036" ref-type="bibr">2015</xref>).</p></sec><sec id="cre270103-sec-0110"><label>2.5</label><title>Multiplex Immunoassay</title><p>For validation of LC&#x02010;MS/MS data, the Quantibody Human Bone Metabolism Array Q1 (RayBiotech Inc., Norcross, GA, USA) with 31 bone&#x02010;related cytokines Supporting information: Table&#x000a0;<xref rid="cre270103-suppl-0002" ref-type="supplementary-material">S1</xref>) was used, as previously described (Shanbhag et al.&#x000a0;<xref rid="cre270103-bib-0044" ref-type="bibr">2023</xref>). This array is based on the sandwich enzyme&#x02010;linked immunosorbent assay (ELISA) technology, which allows simultaneous quantitative measurement of multiple proteins in a sample. Briefly, following the manufacturer's protocol, array hybridization was performed using test samples and standard cytokines on a custom microarray slide (RayBiotech Inc.), where each antibody is spotted in quadruplicate. Array scanning was performed using a laser scanner (GenePix 4000B) and proprietary software (both from Axon Instruments Burladingen, Germany) at different photomultiplier tube gains; the most suitable scan was selected for normalization. Cytokine concentrations were calculated based on linear standard curves and normalized to the corresponding total protein levels (pg/&#x003bc;g total protein); data are presented as fold changes in GF&#x02010;perio CM relative to the reference group.</p></sec><sec id="cre270103-sec-0120"><label>2.6</label><title>Statistical Analysis</title><p>Identification of DEPs was performed using a two&#x02010;sided Student's <italic toggle="yes">t</italic>&#x02010;test with Fisher's correction in Perseus software. FEA was performed using the FunRich open access tool, which applies the hypergeometric test with Bonferroni correction for <italic toggle="yes">p</italic>&#x02010;values. All other statistical analyses were performed using the Prism 9 software (GraphPad Software, San Diego, CA, USA). Linear data are presented as means (&#x000b1;SD), unless specified. Normality testing was performed using Shapiro&#x02013;Wilk test and independent sample <italic toggle="yes">t&#x02010;</italic>tests with a 0.05 significance level were applied.</p></sec></sec><sec sec-type="results" id="cre270103-sec-0130"><label>3</label><title>Results</title><sec id="cre270103-sec-0140"><label>3.1</label><title>Proteomic Profile of GF&#x02010;Perio Secretomes</title><p>LC&#x02010;MS/MS revealed a total of 1833 proteins in GF&#x02010;perio CM, slightly more than in the healthy reference group (<italic toggle="yes">n</italic>&#x02009;=&#x02009;1817). Protein intensity correlation analysis showed a strong correlation between GF&#x02010;perio donors with an average Pearson <italic toggle="yes">R</italic> value of 0.93 (range 0.90&#x02013;0.95). Compared to the healthy reference group, GF&#x02010;perio CM revealed:
<list list-type="simple"><list-item><label>a.</label><p>More exclusive proteins (<italic toggle="yes">n</italic>&#x02009;=&#x02009;127 vs. 111), that is, proteins detected only in GF&#x02010;perio CM, and</p></list-item><list-item><label>b.</label><p>More DEPs (<italic toggle="yes">n</italic>&#x02009;=&#x02009;73 vs. 0), that is, proteins with significantly greater abundance (Figure&#x000a0;<xref rid="cre270103-fig-0001" ref-type="fig">1</xref>, Table&#x000a0;<xref rid="cre270103-tbl-0001" ref-type="table">1</xref>).</p></list-item></list>
</p><fig position="float" fig-type="Figure" id="cre270103-fig-0001"><label>Figure 1</label><caption><p>Proteomic analysis of GF&#x02010;perio secretomes. (A) Venn diagram showing numbers of common and exclusive proteins in GF&#x02010;perio conditioned media (CM) relative to the healthy GF reference group. (B) Volcano plot showing statistically significant differentially expressed proteins (DEPs) versus magnitude of expression change; the <italic toggle="yes">x</italic>&#x02010;axis represents the differences in the mean of protein expression between each group, and the y&#x02010;axis represents the significance level of expression difference (&#x02212;log10 <italic toggle="yes">p&#x02010;</italic>value). All upregulated proteins (<italic toggle="yes">n</italic>&#x02009;=&#x02009;73) were detected in GF&#x02010;perio CM.</p></caption><graphic xlink:href="CRE2-11-e70103-g002" position="anchor" id="jats-graphic-1"/></fig><table-wrap position="float" id="cre270103-tbl-0001" content-type="Table"><label>Table 1</label><caption><p>List of differentially expressed proteins (DEPs) in GF&#x02010;perio CM.</p></caption><table frame="hsides" rules="groups"><col align="left" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000" valign="bottom"><th align="left" valign="bottom" rowspan="1" colspan="1">Accession</th><th align="center" valign="bottom" rowspan="1" colspan="1">Gene symbol</th><th align="center" valign="bottom" rowspan="1" colspan="1">Description</th><th align="center" valign="bottom" rowspan="1" colspan="1">&#x02212;Log(<italic toggle="yes">p</italic> value)<xref rid="cre270103-tbl1-note-0001" ref-type="table-fn">*</xref>
</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">Q5T4S7</td><td align="center" valign="top" rowspan="1" colspan="1">UBR4</td><td align="center" valign="top" rowspan="1" colspan="1">E3 ubiquitin&#x02010;protein ligase UBR4</td><td align="center" valign="top" rowspan="1" colspan="1">3.5</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P33151</td><td align="center" valign="top" rowspan="1" colspan="1">CDH5</td><td align="center" valign="top" rowspan="1" colspan="1">Cadherin&#x02010;5</td><td align="center" valign="top" rowspan="1" colspan="1">3.3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">O95497</td><td align="center" valign="top" rowspan="1" colspan="1">VNN1</td><td align="center" valign="top" rowspan="1" colspan="1">Pantetheinase</td><td align="center" valign="top" rowspan="1" colspan="1">3.2</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P05452</td><td align="center" valign="top" rowspan="1" colspan="1">CLEC3B</td><td align="center" valign="top" rowspan="1" colspan="1">Tetranectin</td><td align="center" valign="top" rowspan="1" colspan="1">2.7</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Q14515</td><td align="center" valign="top" rowspan="1" colspan="1">SPARCL1</td><td align="center" valign="top" rowspan="1" colspan="1">SPARC&#x02010;like protein 1</td><td align="center" valign="top" rowspan="1" colspan="1">2.6</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P19883</td><td align="center" valign="top" rowspan="1" colspan="1">FST</td><td align="center" valign="top" rowspan="1" colspan="1">Follistatin</td><td align="center" valign="top" rowspan="1" colspan="1">2.4</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P48507</td><td align="center" valign="top" rowspan="1" colspan="1">GCLM</td><td align="center" valign="top" rowspan="1" colspan="1">Glutamate&#x02010;&#x02010;cysteine ligase regulatory subunit</td><td align="center" valign="top" rowspan="1" colspan="1">2.3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Q9UIL1</td><td align="center" valign="top" rowspan="1" colspan="1">SCOC</td><td align="center" valign="top" rowspan="1" colspan="1">Short coiled&#x02010;coil protein</td><td align="center" valign="top" rowspan="1" colspan="1">2.2</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P05198</td><td align="center" valign="top" rowspan="1" colspan="1">EIF2S1</td><td align="center" valign="top" rowspan="1" colspan="1">Eukaryotic translation initiation factor 2 subunit 1</td><td align="center" valign="top" rowspan="1" colspan="1">2.2</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P62263</td><td align="center" valign="top" rowspan="1" colspan="1">RPS14</td><td align="center" valign="top" rowspan="1" colspan="1">40S ribosomal protein S14</td><td align="center" valign="top" rowspan="1" colspan="1">2.2</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P19801</td><td align="center" valign="top" rowspan="1" colspan="1">AOC1</td><td align="center" valign="top" rowspan="1" colspan="1">Amiloride&#x02010;sensitive amine oxidase [copper&#x02010;containing]</td><td align="center" valign="top" rowspan="1" colspan="1">2.1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P08758</td><td align="center" valign="top" rowspan="1" colspan="1">ANXA5</td><td align="center" valign="top" rowspan="1" colspan="1">Annexin A5</td><td align="center" valign="top" rowspan="1" colspan="1">2.1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P19623</td><td align="center" valign="top" rowspan="1" colspan="1">SRM</td><td align="center" valign="top" rowspan="1" colspan="1">Spermidine synthase</td><td align="center" valign="top" rowspan="1" colspan="1">2.1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Q9Y224</td><td align="center" valign="top" rowspan="1" colspan="1">RTRAF</td><td align="center" valign="top" rowspan="1" colspan="1">RNA transcription, translation and transport factor protein</td><td align="center" valign="top" rowspan="1" colspan="1">2.0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Q9Y3F4</td><td align="center" valign="top" rowspan="1" colspan="1">STRAP</td><td align="center" valign="top" rowspan="1" colspan="1">Serine&#x02010;threonine kinase receptor&#x02010;associated protein</td><td align="center" valign="top" rowspan="1" colspan="1">2.0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P62191</td><td align="center" valign="top" rowspan="1" colspan="1">PSMC1</td><td align="center" valign="top" rowspan="1" colspan="1">26S proteasome regulatory subunit 4</td><td align="center" valign="top" rowspan="1" colspan="1">2.0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P02753</td><td align="center" valign="top" rowspan="1" colspan="1">RBP4</td><td align="center" valign="top" rowspan="1" colspan="1">Retinol&#x02010;binding protein 4</td><td align="center" valign="top" rowspan="1" colspan="1">1.9</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Q9NPH3</td><td align="center" valign="top" rowspan="1" colspan="1">IL1RAP</td><td align="center" valign="top" rowspan="1" colspan="1">Interleukin&#x02010;1 receptor accessory protein</td><td align="center" valign="top" rowspan="1" colspan="1">1.9</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Q9UL46</td><td align="center" valign="top" rowspan="1" colspan="1">PSME2</td><td align="center" valign="top" rowspan="1" colspan="1">Proteasome activator complex subunit 2</td><td align="center" valign="top" rowspan="1" colspan="1">1.9</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Q9H2D6</td><td align="center" valign="top" rowspan="1" colspan="1">TRIOBP</td><td align="center" valign="top" rowspan="1" colspan="1">TRIO and F&#x02010;actin&#x02010;binding protein</td><td align="center" valign="top" rowspan="1" colspan="1">1.9</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Q99471</td><td align="center" valign="top" rowspan="1" colspan="1">PFDN5</td><td align="center" valign="top" rowspan="1" colspan="1">Prefoldin subunit 5</td><td align="center" valign="top" rowspan="1" colspan="1">1.9</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P11464</td><td align="center" valign="top" rowspan="1" colspan="1">PSG1</td><td align="center" valign="top" rowspan="1" colspan="1">Pregnancy&#x02010;specific beta&#x02010;1&#x02010;glycoprotein 1</td><td align="center" valign="top" rowspan="1" colspan="1">1.9</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Q96IZ0</td><td align="center" valign="top" rowspan="1" colspan="1">PAWR</td><td align="center" valign="top" rowspan="1" colspan="1">PRKC apoptosis WT1 regulator protein</td><td align="center" valign="top" rowspan="1" colspan="1">1.8</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P32321</td><td align="center" valign="top" rowspan="1" colspan="1">DCTD</td><td align="center" valign="top" rowspan="1" colspan="1">Deoxycytidylate deaminase</td><td align="center" valign="top" rowspan="1" colspan="1">1.8</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">O95834</td><td align="center" valign="top" rowspan="1" colspan="1">EML2</td><td align="center" valign="top" rowspan="1" colspan="1">Echinoderm microtubule&#x02010;associated protein&#x02010;like 2</td><td align="center" valign="top" rowspan="1" colspan="1">1.8</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Q7Z6Z7</td><td align="center" valign="top" rowspan="1" colspan="1">HUWE1</td><td align="center" valign="top" rowspan="1" colspan="1">E3 ubiquitin&#x02010;protein ligase HUWE1</td><td align="center" valign="top" rowspan="1" colspan="1">1.8</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Q6V0I7</td><td align="center" valign="top" rowspan="1" colspan="1">FAT4</td><td align="center" valign="top" rowspan="1" colspan="1">Protocadherin Fat 4</td><td align="center" valign="top" rowspan="1" colspan="1">1.8</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">O14976</td><td align="center" valign="top" rowspan="1" colspan="1">GAK</td><td align="center" valign="top" rowspan="1" colspan="1">Cyclin&#x02010;G&#x02010;associated kinase</td><td align="center" valign="top" rowspan="1" colspan="1">1.8</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P05386</td><td align="center" valign="top" rowspan="1" colspan="1">RPLP1</td><td align="center" valign="top" rowspan="1" colspan="1">60S acidic ribosomal protein P1</td><td align="center" valign="top" rowspan="1" colspan="1">1.8</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P52788</td><td align="center" valign="top" rowspan="1" colspan="1">SMS</td><td align="center" valign="top" rowspan="1" colspan="1">Spermine synthase</td><td align="center" valign="top" rowspan="1" colspan="1">1.8</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P49458</td><td align="center" valign="top" rowspan="1" colspan="1">SRP9</td><td align="center" valign="top" rowspan="1" colspan="1">Signal recognition particle 9&#x02009;kDa protein</td><td align="center" valign="top" rowspan="1" colspan="1">1.8</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Q92905</td><td align="center" valign="top" rowspan="1" colspan="1">COPS5</td><td align="center" valign="top" rowspan="1" colspan="1">COP9 signalosome complex subunit 5</td><td align="center" valign="top" rowspan="1" colspan="1">1.8</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Q9H0R8</td><td align="center" valign="top" rowspan="1" colspan="1">GABARAPL1</td><td align="center" valign="top" rowspan="1" colspan="1">Gamma&#x02010;aminobutyric acid receptor&#x02010;associated protein&#x02010;like 1</td><td align="center" valign="top" rowspan="1" colspan="1">1.7</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Q08174</td><td align="center" valign="top" rowspan="1" colspan="1">PCDH1</td><td align="center" valign="top" rowspan="1" colspan="1">Protocadherin&#x02010;1</td><td align="center" valign="top" rowspan="1" colspan="1">1.7</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Q96RF0</td><td align="center" valign="top" rowspan="1" colspan="1">SNX18</td><td align="center" valign="top" rowspan="1" colspan="1">Sorting nexin&#x02010;18</td><td align="center" valign="top" rowspan="1" colspan="1">1.7</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Q06124</td><td align="center" valign="top" rowspan="1" colspan="1">PTPN11</td><td align="center" valign="top" rowspan="1" colspan="1">Tyrosine&#x02010;protein phosphatase non&#x02010;receptor type 11</td><td align="center" valign="top" rowspan="1" colspan="1">1.7</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Q06323</td><td align="center" valign="top" rowspan="1" colspan="1">PSME1</td><td align="center" valign="top" rowspan="1" colspan="1">Proteasome activator complex subunit 1</td><td align="center" valign="top" rowspan="1" colspan="1">1.7</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P61587</td><td align="center" valign="top" rowspan="1" colspan="1">RND3</td><td align="center" valign="top" rowspan="1" colspan="1">Rho&#x02010;related GTP&#x02010;binding protein RhoE</td><td align="center" valign="top" rowspan="1" colspan="1">1.6</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P49902</td><td align="center" valign="top" rowspan="1" colspan="1">NT5C2</td><td align="center" valign="top" rowspan="1" colspan="1">Cytosolic purine 5&#x02032;&#x02010;nucleotidase</td><td align="center" valign="top" rowspan="1" colspan="1">1.6</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P07437</td><td align="center" valign="top" rowspan="1" colspan="1">TUBB</td><td align="center" valign="top" rowspan="1" colspan="1">Tubulin beta chain</td><td align="center" valign="top" rowspan="1" colspan="1">1.6</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Q9UKK9</td><td align="center" valign="top" rowspan="1" colspan="1">NUDT5</td><td align="center" valign="top" rowspan="1" colspan="1">ADP&#x02010;sugar pyrophosphatase</td><td align="center" valign="top" rowspan="1" colspan="1">1.6</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">O00154</td><td align="center" valign="top" rowspan="1" colspan="1">ACOT7</td><td align="center" valign="top" rowspan="1" colspan="1">Cytosolic acyl coenzyme A thioester hydrolase</td><td align="center" valign="top" rowspan="1" colspan="1">1.6</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P50583</td><td align="center" valign="top" rowspan="1" colspan="1">NUDT2</td><td align="center" valign="top" rowspan="1" colspan="1">Bis(5&#x02032;&#x02010;nucleosyl)&#x02010;tetraphosphatase [asymmetrical]</td><td align="center" valign="top" rowspan="1" colspan="1">1.6</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P07355</td><td align="center" valign="top" rowspan="1" colspan="1">ANXA2</td><td align="center" valign="top" rowspan="1" colspan="1">Annexin A2</td><td align="center" valign="top" rowspan="1" colspan="1">1.5</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Q14012</td><td align="center" valign="top" rowspan="1" colspan="1">CAMK1</td><td align="center" valign="top" rowspan="1" colspan="1">Calcium/calmodulin&#x02010;dependent protein kinase type 1</td><td align="center" valign="top" rowspan="1" colspan="1">1.5</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Q9UP95</td><td align="center" valign="top" rowspan="1" colspan="1">SLC12A4</td><td align="center" valign="top" rowspan="1" colspan="1">Solute carrier family 12 member 4</td><td align="center" valign="top" rowspan="1" colspan="1">1.5</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P61201</td><td align="center" valign="top" rowspan="1" colspan="1">COPS2</td><td align="center" valign="top" rowspan="1" colspan="1">COP9 signalosome complex subunit 2</td><td align="center" valign="top" rowspan="1" colspan="1">1.5</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Q96FJ0</td><td align="center" valign="top" rowspan="1" colspan="1">STAMBPL1</td><td align="center" valign="top" rowspan="1" colspan="1">AMSH&#x02010;like protease</td><td align="center" valign="top" rowspan="1" colspan="1">1.5</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P62495</td><td align="center" valign="top" rowspan="1" colspan="1">ETF1</td><td align="center" valign="top" rowspan="1" colspan="1">Eukaryotic peptide chain release factor subunit 1</td><td align="center" valign="top" rowspan="1" colspan="1">1.5</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P33991</td><td align="center" valign="top" rowspan="1" colspan="1">MCM4</td><td align="center" valign="top" rowspan="1" colspan="1">DNA replication licensing factor MCM4</td><td align="center" valign="top" rowspan="1" colspan="1">1.5</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Q8WWZ4</td><td align="center" valign="top" rowspan="1" colspan="1">ABCA10</td><td align="center" valign="top" rowspan="1" colspan="1">ATP&#x02010;binding cassette sub&#x02010;family A member 10</td><td align="center" valign="top" rowspan="1" colspan="1">1.5</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Q16774</td><td align="center" valign="top" rowspan="1" colspan="1">GUK1</td><td align="center" valign="top" rowspan="1" colspan="1">Guanylate kinase</td><td align="center" valign="top" rowspan="1" colspan="1">1.5</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">O14950</td><td align="center" valign="top" rowspan="1" colspan="1">MYL12B</td><td align="center" valign="top" rowspan="1" colspan="1">Myosin regulatory light chain 12B</td><td align="center" valign="top" rowspan="1" colspan="1">1.5</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Q53H82</td><td align="center" valign="top" rowspan="1" colspan="1">LACTB2</td><td align="center" valign="top" rowspan="1" colspan="1">Endoribonuclease LACTB2</td><td align="center" valign="top" rowspan="1" colspan="1">1.5</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P06730</td><td align="center" valign="top" rowspan="1" colspan="1">EIF4E</td><td align="center" valign="top" rowspan="1" colspan="1">Eukaryotic translation initiation factor 4E</td><td align="center" valign="top" rowspan="1" colspan="1">1.5</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P60981</td><td align="center" valign="top" rowspan="1" colspan="1">DSTN</td><td align="center" valign="top" rowspan="1" colspan="1">Destrin</td><td align="center" valign="top" rowspan="1" colspan="1">1.5</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P07195</td><td align="center" valign="top" rowspan="1" colspan="1">LDHB</td><td align="center" valign="top" rowspan="1" colspan="1">
<sc>l</sc>&#x02010;lactate dehydrogenase B chain</td><td align="center" valign="top" rowspan="1" colspan="1">1.4</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Q7Z3B1</td><td align="center" valign="top" rowspan="1" colspan="1">NEGR1</td><td align="center" valign="top" rowspan="1" colspan="1">Neuronal growth regulator 1</td><td align="center" valign="top" rowspan="1" colspan="1">1.4</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Q9NX46</td><td align="center" valign="top" rowspan="1" colspan="1">ADPRS</td><td align="center" valign="top" rowspan="1" colspan="1">ADP&#x02010;ribosylhydrolase ARH3</td><td align="center" valign="top" rowspan="1" colspan="1">1.4</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P13591</td><td align="center" valign="top" rowspan="1" colspan="1">NCAM1</td><td align="center" valign="top" rowspan="1" colspan="1">Neural cell adhesion molecule 1</td><td align="center" valign="top" rowspan="1" colspan="1">1.4</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P07225</td><td align="center" valign="top" rowspan="1" colspan="1">PROS1</td><td align="center" valign="top" rowspan="1" colspan="1">Vitamin K&#x02010;dependent protein S</td><td align="center" valign="top" rowspan="1" colspan="1">1.4</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P22061</td><td align="center" valign="top" rowspan="1" colspan="1">PCMT1</td><td align="center" valign="top" rowspan="1" colspan="1">Protein&#x02010;<sc>l</sc>&#x02010;isoaspartate(<sc>d</sc>&#x02010;aspartate) O&#x02010;methyltransferase</td><td align="center" valign="top" rowspan="1" colspan="1">1.4</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P62826</td><td align="center" valign="top" rowspan="1" colspan="1">RAN</td><td align="center" valign="top" rowspan="1" colspan="1">GTP&#x02010;binding nuclear protein Ran</td><td align="center" valign="top" rowspan="1" colspan="1">1.4</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">O60220</td><td align="center" valign="top" rowspan="1" colspan="1">TIMM8A</td><td align="center" valign="top" rowspan="1" colspan="1">Mitochondrial import inner membrane translocase subunit Tim8 A</td><td align="center" valign="top" rowspan="1" colspan="1">1.4</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P48681</td><td align="center" valign="top" rowspan="1" colspan="1">NES</td><td align="center" valign="top" rowspan="1" colspan="1">Nestin</td><td align="center" valign="top" rowspan="1" colspan="1">1.4</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P21980</td><td align="center" valign="top" rowspan="1" colspan="1">TGM2</td><td align="center" valign="top" rowspan="1" colspan="1">Protein&#x02010;glutamine gamma&#x02010;glutamyltransferase 2</td><td align="center" valign="top" rowspan="1" colspan="1">1.4</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Q9Y2Q3</td><td align="center" valign="top" rowspan="1" colspan="1">GSTK1</td><td align="center" valign="top" rowspan="1" colspan="1">Glutathione S&#x02010;transferase kappa 1</td><td align="center" valign="top" rowspan="1" colspan="1">1.4</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P51178</td><td align="center" valign="top" rowspan="1" colspan="1">PLCD1</td><td align="center" valign="top" rowspan="1" colspan="1">1&#x02010;phosphatidylinositol 4,5&#x02010;bisphosphate phosphodiesterase delta&#x02010;1</td><td align="center" valign="top" rowspan="1" colspan="1">1.3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Q53QV2</td><td align="center" valign="top" rowspan="1" colspan="1">LBH</td><td align="center" valign="top" rowspan="1" colspan="1">Protein LBH</td><td align="center" valign="top" rowspan="1" colspan="1">1.3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">O95433</td><td align="center" valign="top" rowspan="1" colspan="1">AHSA1</td><td align="center" valign="top" rowspan="1" colspan="1">Activator of 90&#x02009;kDa heat shock protein ATPase homolog 1</td><td align="center" valign="top" rowspan="1" colspan="1">1.3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Q96IU4</td><td align="center" valign="top" rowspan="1" colspan="1">ABHD14B</td><td align="center" valign="top" rowspan="1" colspan="1">Putative protein&#x02010;lysine deacylase ABHD14B</td><td align="center" valign="top" rowspan="1" colspan="1">1.3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Q9BUF5</td><td align="center" valign="top" rowspan="1" colspan="1">TUBB6</td><td align="center" valign="top" rowspan="1" colspan="1">Tubulin beta&#x02010;6 chain</td><td align="center" valign="top" rowspan="1" colspan="1">1.3</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P30044</td><td align="center" valign="top" rowspan="1" colspan="1">PRDX5</td><td align="center" valign="top" rowspan="1" colspan="1">Peroxiredoxin&#x02010;5, mitochondrial</td><td align="center" valign="top" rowspan="1" colspan="1">1.3</td></tr></tbody></table><table-wrap-foot><fn id="cre270103-tbl1-note-0001"><label>*</label><p>&#x02212;log10(Students <italic toggle="yes">t</italic>&#x02010;test <italic toggle="yes">p</italic>&#x02010;value).</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap></sec><sec id="cre270103-sec-0150"><label>3.2</label><title>Functional Analysis of Proteins in GF&#x02010;Perio Secretomes</title><p>GO profiling of the total proteins in GF&#x02010;perio CM revealed enrichment of specific categories according to CC, MF, and BP. Among the top 10 enriched categories certain CC (&#x0201c;extracellular matrix&#x0201d;), MF (&#x0201c;protein binding&#x0201d;), and BP terms (&#x0201c;adaptive immune response&#x0201d;) were directly related to wound healing (Table&#x000a0;<xref rid="cre270103-tbl-0002" ref-type="table">2</xref>). Next, FEA was performed to determine specifically enriched categories of proteins among the DEPs (relative to the reference group) and exclusive proteins (independent of the reference group) in GF&#x02010;perio CM. Among the top 10 enriched categories in DEPs, the CC categories of &#x0201c;exosomes&#x0201d; and &#x0201c;cytoplasm&#x0201d; were statistically significant (<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05 according to multiple testing) (Table&#x000a0;<xref rid="cre270103-tbl-0003" ref-type="table">3</xref>). Similarly, among the <italic toggle="yes">exclusive</italic> proteins, the CC categories of &#x0201c;exosomes,&#x0201d; &#x0201c;lysosomes&#x0201d; and &#x0201c;cytoplasm,&#x0201d; and the MF category of &#x0201c;chaperone activity,&#x0201d; were significantly enriched (<italic toggle="yes">p</italic>&#x02009;&#x0003c;&#x02009;0.05 according to multiple testing) in GF&#x02010;perio CM (Table&#x000a0;<xref rid="cre270103-tbl-0004" ref-type="table">4</xref>).</p><table-wrap position="float" id="cre270103-tbl-0002" content-type="Table"><label>Table 2</label><caption><p>Top 10 enriched GO categories among the total proteins in GF&#x02010;perio CM.</p></caption><table frame="hsides" rules="groups"><col align="left" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000" valign="bottom"><th align="left" valign="bottom" rowspan="1" colspan="1">Category term name</th><th align="center" valign="bottom" rowspan="1" colspan="1">Term id</th><th align="center" valign="bottom" rowspan="1" colspan="1">Adjusted <italic toggle="yes">p</italic> value</th><th align="center" valign="bottom" rowspan="1" colspan="1">&#x02212;log10 (adjusted <italic toggle="yes">p</italic>&#x02010;value)</th><th align="center" valign="bottom" rowspan="1" colspan="1">Term size</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Cellular component</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cytoplasm</td><td align="center" valign="top" rowspan="1" colspan="1">GO:0005737</td><td align="center" valign="top" rowspan="1" colspan="1">0.0000</td><td align="center" valign="top" rowspan="1" colspan="1">323.31</td><td align="center" valign="top" rowspan="1" colspan="1">12345</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Extracellular matrix</td><td align="center" valign="top" rowspan="1" colspan="1">GO:0031012</td><td align="center" valign="top" rowspan="1" colspan="1">0.0000</td><td align="center" valign="top" rowspan="1" colspan="1">123.56</td><td align="center" valign="top" rowspan="1" colspan="1">555</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Spliceosomal complex</td><td align="center" valign="top" rowspan="1" colspan="1">GO:0005681</td><td align="center" valign="top" rowspan="1" colspan="1">0.0000</td><td align="center" valign="top" rowspan="1" colspan="1">38.08</td><td align="center" valign="top" rowspan="1" colspan="1">206</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Nuclear lamina</td><td align="center" valign="top" rowspan="1" colspan="1">GO:0005652</td><td align="center" valign="top" rowspan="1" colspan="1">0.0003</td><td align="center" valign="top" rowspan="1" colspan="1">3.53</td><td align="center" valign="top" rowspan="1" colspan="1">13</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Serine/threonine protein kinase complex</td><td align="center" valign="top" rowspan="1" colspan="1">GO:1902554</td><td align="center" valign="top" rowspan="1" colspan="1">0.0046</td><td align="center" valign="top" rowspan="1" colspan="1">2.33</td><td align="center" valign="top" rowspan="1" colspan="1">139</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Lsm2&#x02010;8 complex</td><td align="center" valign="top" rowspan="1" colspan="1">GO:0120115</td><td align="center" valign="top" rowspan="1" colspan="1">0.0080</td><td align="center" valign="top" rowspan="1" colspan="1">2.10</td><td align="center" valign="top" rowspan="1" colspan="1">7</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">PTW/PP1 phosphatase complex</td><td align="center" valign="top" rowspan="1" colspan="1">GO:0072357</td><td align="center" valign="top" rowspan="1" colspan="1">0.0080</td><td align="center" valign="top" rowspan="1" colspan="1">2.10</td><td align="center" valign="top" rowspan="1" colspan="1">7</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Sperm flagellum</td><td align="center" valign="top" rowspan="1" colspan="1">GO:0036126</td><td align="center" valign="top" rowspan="1" colspan="1">0.0108</td><td align="center" valign="top" rowspan="1" colspan="1">1.97</td><td align="center" valign="top" rowspan="1" colspan="1">167</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cytoplasmic dynein complex</td><td align="center" valign="top" rowspan="1" colspan="1">GO:0005868</td><td align="center" valign="top" rowspan="1" colspan="1">0.0135</td><td align="center" valign="top" rowspan="1" colspan="1">1.87</td><td align="center" valign="top" rowspan="1" colspan="1">23</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">MHC class I protein complex</td><td align="center" valign="top" rowspan="1" colspan="1">GO:0042612</td><td align="center" valign="top" rowspan="1" colspan="1">0.0156</td><td align="center" valign="top" rowspan="1" colspan="1">1.81</td><td align="center" valign="top" rowspan="1" colspan="1">8</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Molecular function</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Protein binding</td><td align="center" valign="top" rowspan="1" colspan="1">GO:0005515</td><td align="center" valign="top" rowspan="1" colspan="1">0.0000</td><td align="center" valign="top" rowspan="1" colspan="1">323.31</td><td align="center" valign="top" rowspan="1" colspan="1">14838</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Exopeptidase activity</td><td align="center" valign="top" rowspan="1" colspan="1">GO:0008238</td><td align="center" valign="top" rowspan="1" colspan="1">0.0000</td><td align="center" valign="top" rowspan="1" colspan="1">22.38</td><td align="center" valign="top" rowspan="1" colspan="1">101</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Hydrolase activity, acting on glycosyl bonds</td><td align="center" valign="top" rowspan="1" colspan="1">GO:0016798</td><td align="center" valign="top" rowspan="1" colspan="1">0.0000</td><td align="center" valign="top" rowspan="1" colspan="1">16.88</td><td align="center" valign="top" rowspan="1" colspan="1">135</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Disulfide oxidoreductase activity</td><td align="center" valign="top" rowspan="1" colspan="1">GO:0015036</td><td align="center" valign="top" rowspan="1" colspan="1">0.0000</td><td align="center" valign="top" rowspan="1" colspan="1">15.96</td><td align="center" valign="top" rowspan="1" colspan="1">39</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">NADP binding</td><td align="center" valign="top" rowspan="1" colspan="1">GO:0050661</td><td align="center" valign="top" rowspan="1" colspan="1">0.0000</td><td align="center" valign="top" rowspan="1" colspan="1">7.05</td><td align="center" valign="top" rowspan="1" colspan="1">52</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Telomeric DNA binding</td><td align="center" valign="top" rowspan="1" colspan="1">GO:0042162</td><td align="center" valign="top" rowspan="1" colspan="1">0.0000</td><td align="center" valign="top" rowspan="1" colspan="1">5.45</td><td align="center" valign="top" rowspan="1" colspan="1">38</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Supercoiled DNA binding</td><td align="center" valign="top" rowspan="1" colspan="1">GO:0097100</td><td align="center" valign="top" rowspan="1" colspan="1">0.0000</td><td align="center" valign="top" rowspan="1" colspan="1">4.98</td><td align="center" valign="top" rowspan="1" colspan="1">5</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Sulfuric ester hydrolase activity</td><td align="center" valign="top" rowspan="1" colspan="1">GO:0008484</td><td align="center" valign="top" rowspan="1" colspan="1">0.0003</td><td align="center" valign="top" rowspan="1" colspan="1">3.49</td><td align="center" valign="top" rowspan="1" colspan="1">19</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Malate dehydrogenase activity</td><td align="center" valign="top" rowspan="1" colspan="1">GO:0016615</td><td align="center" valign="top" rowspan="1" colspan="1">0.0005</td><td align="center" valign="top" rowspan="1" colspan="1">3.26</td><td align="center" valign="top" rowspan="1" colspan="1">8</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Transferase activity, transferring nitrogenous groups</td><td align="center" valign="top" rowspan="1" colspan="1">GO:0016769</td><td align="center" valign="top" rowspan="1" colspan="1">0.0006</td><td align="center" valign="top" rowspan="1" colspan="1">3.20</td><td align="center" valign="top" rowspan="1" colspan="1">29</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Biological process</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">U2&#x02010;type prespliceosome assembly</td><td align="center" valign="top" rowspan="1" colspan="1">GO:1903241</td><td align="center" valign="top" rowspan="1" colspan="1">0.0000</td><td align="center" valign="top" rowspan="1" colspan="1">7.36</td><td align="center" valign="top" rowspan="1" colspan="1">24</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains</td><td align="center" valign="top" rowspan="1" colspan="1">GO:0002460</td><td align="center" valign="top" rowspan="1" colspan="1">0.0015</td><td align="center" valign="top" rowspan="1" colspan="1">2.82</td><td align="center" valign="top" rowspan="1" colspan="1">375</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Sensory perception of mechanical stimulus</td><td align="center" valign="top" rowspan="1" colspan="1">GO:0050954</td><td align="center" valign="top" rowspan="1" colspan="1">0.0057</td><td align="center" valign="top" rowspan="1" colspan="1">2.24</td><td align="center" valign="top" rowspan="1" colspan="1">188</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Iron ion transport</td><td align="center" valign="top" rowspan="1" colspan="1">GO:0006826</td><td align="center" valign="top" rowspan="1" colspan="1">0.0108</td><td align="center" valign="top" rowspan="1" colspan="1">1.97</td><td align="center" valign="top" rowspan="1" colspan="1">57</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Telomerase holoenzyme complex assembly</td><td align="center" valign="top" rowspan="1" colspan="1">GO:1905323</td><td align="center" valign="top" rowspan="1" colspan="1">0.0216</td><td align="center" valign="top" rowspan="1" colspan="1">1.66</td><td align="center" valign="top" rowspan="1" colspan="1">6</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Water&#x02010;soluble vitamin biosynthetic process</td><td align="center" valign="top" rowspan="1" colspan="1">GO:0042364</td><td align="center" valign="top" rowspan="1" colspan="1">0.0291</td><td align="center" valign="top" rowspan="1" colspan="1">1.54</td><td align="center" valign="top" rowspan="1" colspan="1">12</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion</td><td align="center" valign="top" rowspan="1" colspan="1">GO:0010881</td><td align="center" valign="top" rowspan="1" colspan="1">0.0469</td><td align="center" valign="top" rowspan="1" colspan="1">1.33</td><td align="center" valign="top" rowspan="1" colspan="1">21</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Amyloid&#x02010;beta clearance by transcytosis</td><td align="center" valign="top" rowspan="1" colspan="1">GO:0150093</td><td align="center" valign="top" rowspan="1" colspan="1">0.0493</td><td align="center" valign="top" rowspan="1" colspan="1">1.31</td><td align="center" valign="top" rowspan="1" colspan="1">7</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Trachea formation</td><td align="center" valign="top" rowspan="1" colspan="1">GO:0060440</td><td align="center" valign="top" rowspan="1" colspan="1">0.0493</td><td align="center" valign="top" rowspan="1" colspan="1">1.31</td><td align="center" valign="top" rowspan="1" colspan="1">7</td></tr></tbody></table><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap><table-wrap position="float" id="cre270103-tbl-0003" content-type="Table"><label>Table 3</label><caption><p>Top 10 enriched GO categories among the DEPs in GF&#x02010;perio CM.</p></caption><table frame="hsides" rules="groups"><col align="left" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000" valign="bottom"><th align="left" valign="bottom" rowspan="1" colspan="1">Category</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">N</italic> genes in the data set</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">N</italic> genes in the background data set</th><th align="center" valign="bottom" rowspan="1" colspan="1">Percentage of genes</th><th align="center" valign="bottom" rowspan="1" colspan="1">Fold enrichment</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic> value (Hypergeometric test)</th><th align="center" valign="bottom" rowspan="1" colspan="1">Bonferroni method</th><th align="center" valign="bottom" rowspan="1" colspan="1">BH method</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Cellular component</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Exosomes</td><td align="center" valign="top" rowspan="1" colspan="1">26</td><td align="center" valign="top" rowspan="1" colspan="1">2043</td><td align="center" valign="top" rowspan="1" colspan="1">37.68</td><td align="center" valign="top" rowspan="1" colspan="1">2.68</td><td align="center" valign="top" rowspan="1" colspan="1">0.0000</td><td align="center" valign="top" rowspan="1" colspan="1">0.0007</td><td align="center" valign="top" rowspan="1" colspan="1">0.0004</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cytoplasm</td><td align="center" valign="top" rowspan="1" colspan="1">47</td><td align="center" valign="top" rowspan="1" colspan="1">5684</td><td align="center" valign="top" rowspan="1" colspan="1">68.12</td><td align="center" valign="top" rowspan="1" colspan="1">1.74</td><td align="center" valign="top" rowspan="1" colspan="1">0.0000</td><td align="center" valign="top" rowspan="1" colspan="1">0.0007</td><td align="center" valign="top" rowspan="1" colspan="1">0.0004</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Signalosome</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">2.90</td><td align="center" valign="top" rowspan="1" colspan="1">140.82</td><td align="center" valign="top" rowspan="1" colspan="1">0.0001</td><td align="center" valign="top" rowspan="1" colspan="1">0.0519</td><td align="center" valign="top" rowspan="1" colspan="1">0.0173</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Intracellular</td><td align="center" valign="top" rowspan="1" colspan="1">5</td><td align="center" valign="top" rowspan="1" colspan="1">151</td><td align="center" valign="top" rowspan="1" colspan="1">7.25</td><td align="center" valign="top" rowspan="1" colspan="1">7.00</td><td align="center" valign="top" rowspan="1" colspan="1">0.0007</td><td align="center" valign="top" rowspan="1" colspan="1">0.5813</td><td align="center" valign="top" rowspan="1" colspan="1">0.1453</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Intermediate filament cytoskeleton</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">11</td><td align="center" valign="top" rowspan="1" colspan="1">2.90</td><td align="center" valign="top" rowspan="1" colspan="1">38.50</td><td align="center" valign="top" rowspan="1" colspan="1">0.0012</td><td align="center" valign="top" rowspan="1" colspan="1">0.9293</td><td align="center" valign="top" rowspan="1" colspan="1">0.1859</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Lysosome</td><td align="center" valign="top" rowspan="1" colspan="1">16</td><td align="center" valign="top" rowspan="1" colspan="1">1620</td><td align="center" valign="top" rowspan="1" colspan="1">23.19</td><td align="center" valign="top" rowspan="1" colspan="1">2.08</td><td align="center" valign="top" rowspan="1" colspan="1">0.0032</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">0.4175</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cytosolic part</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">1.45</td><td align="center" valign="top" rowspan="1" colspan="1">210.88</td><td align="center" valign="top" rowspan="1" colspan="1">0.0047</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">0.4736</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Ribosome</td><td align="center" valign="top" rowspan="1" colspan="1">4</td><td align="center" valign="top" rowspan="1" colspan="1">144</td><td align="center" valign="top" rowspan="1" colspan="1">5.80</td><td align="center" valign="top" rowspan="1" colspan="1">5.87</td><td align="center" valign="top" rowspan="1" colspan="1">0.0048</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">0.4736</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Nucleolus</td><td align="center" valign="top" rowspan="1" colspan="1">13</td><td align="center" valign="top" rowspan="1" colspan="1">1257</td><td align="center" valign="top" rowspan="1" colspan="1">18.84</td><td align="center" valign="top" rowspan="1" colspan="1">2.18</td><td align="center" valign="top" rowspan="1" colspan="1">0.0056</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">0.4895</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Signal recognition particle receptor complex</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">1.45</td><td align="center" valign="top" rowspan="1" colspan="1">105.97</td><td align="center" valign="top" rowspan="1" colspan="1">0.0095</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">0.7417</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Molecular function</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Hydrolase activity</td><td align="center" valign="top" rowspan="1" colspan="1">5</td><td align="center" valign="top" rowspan="1" colspan="1">203</td><td align="center" valign="top" rowspan="1" colspan="1">7.04</td><td align="center" valign="top" rowspan="1" colspan="1">6.30</td><td align="center" valign="top" rowspan="1" colspan="1">0.0012</td><td align="center" valign="top" rowspan="1" colspan="1">0.2688</td><td align="center" valign="top" rowspan="1" colspan="1">0.2298</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Structural constituent of cytoskeleton</td><td align="center" valign="top" rowspan="1" colspan="1">4</td><td align="center" valign="top" rowspan="1" colspan="1">137</td><td align="center" valign="top" rowspan="1" colspan="1">5.63</td><td align="center" valign="top" rowspan="1" colspan="1">7.47</td><td align="center" valign="top" rowspan="1" colspan="1">0.0021</td><td align="center" valign="top" rowspan="1" colspan="1">0.4595</td><td align="center" valign="top" rowspan="1" colspan="1">0.2298</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Translation regulator activity</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">101</td><td align="center" valign="top" rowspan="1" colspan="1">4.23</td><td align="center" valign="top" rowspan="1" colspan="1">7.61</td><td align="center" valign="top" rowspan="1" colspan="1">0.0073</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">0.5449</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Methyltransferase activity</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">59</td><td align="center" valign="top" rowspan="1" colspan="1">2.82</td><td align="center" valign="top" rowspan="1" colspan="1">8.69</td><td align="center" valign="top" rowspan="1" colspan="1">0.0224</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Calcium ion binding</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">185</td><td align="center" valign="top" rowspan="1" colspan="1">4.23</td><td align="center" valign="top" rowspan="1" colspan="1">4.15</td><td align="center" valign="top" rowspan="1" colspan="1">0.0361</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cell adhesion molecule activity</td><td align="center" valign="top" rowspan="1" colspan="1">4</td><td align="center" valign="top" rowspan="1" colspan="1">356</td><td align="center" valign="top" rowspan="1" colspan="1">5.63</td><td align="center" valign="top" rowspan="1" colspan="1">2.88</td><td align="center" valign="top" rowspan="1" colspan="1">0.0510</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cytoskeletal protein binding</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">218</td><td align="center" valign="top" rowspan="1" colspan="1">4.23</td><td align="center" valign="top" rowspan="1" colspan="1">3.52</td><td align="center" valign="top" rowspan="1" colspan="1">0.0541</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Biological process</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Metabolism</td><td align="center" valign="top" rowspan="1" colspan="1">16</td><td align="center" valign="top" rowspan="1" colspan="1">1683</td><td align="center" valign="top" rowspan="1" colspan="1">22.54</td><td align="center" valign="top" rowspan="1" colspan="1">2.43</td><td align="center" valign="top" rowspan="1" colspan="1">0.0007</td><td align="center" valign="top" rowspan="1" colspan="1">0.1173</td><td align="center" valign="top" rowspan="1" colspan="1">0.1173</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Protein metabolism</td><td align="center" valign="top" rowspan="1" colspan="1">13</td><td align="center" valign="top" rowspan="1" colspan="1">1323</td><td align="center" valign="top" rowspan="1" colspan="1">18.31</td><td align="center" valign="top" rowspan="1" colspan="1">2.51</td><td align="center" valign="top" rowspan="1" colspan="1">0.0017</td><td align="center" valign="top" rowspan="1" colspan="1">0.3037</td><td align="center" valign="top" rowspan="1" colspan="1">0.1518</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Energy pathways</td><td align="center" valign="top" rowspan="1" colspan="1">14</td><td align="center" valign="top" rowspan="1" colspan="1">1633</td><td align="center" valign="top" rowspan="1" colspan="1">19.72</td><td align="center" valign="top" rowspan="1" colspan="1">2.19</td><td align="center" valign="top" rowspan="1" colspan="1">0.0040</td><td align="center" valign="top" rowspan="1" colspan="1">0.7038</td><td align="center" valign="top" rowspan="1" colspan="1">0.2346</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cell growth and/or maintenance</td><td align="center" valign="top" rowspan="1" colspan="1">9</td><td align="center" valign="top" rowspan="1" colspan="1">1125</td><td align="center" valign="top" rowspan="1" colspan="1">12.68</td><td align="center" valign="top" rowspan="1" colspan="1">2.04</td><td align="center" valign="top" rowspan="1" colspan="1">0.0310</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">1</td></tr></tbody></table><table-wrap-foot><fn id="cre270103-tbl3-note-0001"><p>Abbreviation: BH, Benjamini&#x02013;Hochberg.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap><table-wrap position="float" id="cre270103-tbl-0004" content-type="Table"><label>Table 4</label><caption><p>Top 10 enriched GO categories among the exclusive proteins in GF&#x02010;perio CM.</p></caption><table frame="hsides" rules="groups"><col align="left" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000" valign="bottom"><th align="left" valign="bottom" rowspan="1" colspan="1">Category</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">N</italic> genes in the data set</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">N</italic> genes in the background data set</th><th align="center" valign="bottom" rowspan="1" colspan="1">Percentage of genes</th><th align="center" valign="bottom" rowspan="1" colspan="1">Fold enrichment</th><th align="center" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p&#x02010;</italic>value (Hypergeometric test)</th><th align="center" valign="bottom" rowspan="1" colspan="1">Bonferroni method</th><th align="center" valign="bottom" rowspan="1" colspan="1">BH method</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Cellular component</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Exosomes</td><td align="center" valign="top" rowspan="1" colspan="1">34</td><td align="center" valign="top" rowspan="1" colspan="1">2043</td><td align="center" valign="top" rowspan="1" colspan="1">30.91</td><td align="center" valign="top" rowspan="1" colspan="1">2.20</td><td align="center" valign="top" rowspan="1" colspan="1">0.0000</td><td align="center" valign="top" rowspan="1" colspan="1">0.0032</td><td align="center" valign="top" rowspan="1" colspan="1">0.0032</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Lysosome</td><td align="center" valign="top" rowspan="1" colspan="1">28</td><td align="center" valign="top" rowspan="1" colspan="1">1620</td><td align="center" valign="top" rowspan="1" colspan="1">25.45</td><td align="center" valign="top" rowspan="1" colspan="1">2.29</td><td align="center" valign="top" rowspan="1" colspan="1">0.0000</td><td align="center" valign="top" rowspan="1" colspan="1">0.0152</td><td align="center" valign="top" rowspan="1" colspan="1">0.0076</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cytoplasm</td><td align="center" valign="top" rowspan="1" colspan="1">64</td><td align="center" valign="top" rowspan="1" colspan="1">5684</td><td align="center" valign="top" rowspan="1" colspan="1">58.18</td><td align="center" valign="top" rowspan="1" colspan="1">1.49</td><td align="center" valign="top" rowspan="1" colspan="1">0.0000</td><td align="center" valign="top" rowspan="1" colspan="1">0.0283</td><td align="center" valign="top" rowspan="1" colspan="1">0.0094</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cytosol</td><td align="center" valign="top" rowspan="1" colspan="1">20</td><td align="center" valign="top" rowspan="1" colspan="1">1178</td><td align="center" valign="top" rowspan="1" colspan="1">18.18</td><td align="center" valign="top" rowspan="1" colspan="1">2.25</td><td align="center" valign="top" rowspan="1" colspan="1">0.0005</td><td align="center" valign="top" rowspan="1" colspan="1">0.3765</td><td align="center" valign="top" rowspan="1" colspan="1">0.0941</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Postsynaptic membrane</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">7</td><td align="center" valign="top" rowspan="1" colspan="1">1.82</td><td align="center" valign="top" rowspan="1" colspan="1">37.93</td><td align="center" valign="top" rowspan="1" colspan="1">0.0012</td><td align="center" valign="top" rowspan="1" colspan="1">0.9093</td><td align="center" valign="top" rowspan="1" colspan="1">0.1819</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Platelet alpha granule lumen</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">35</td><td align="center" valign="top" rowspan="1" colspan="1">2.73</td><td align="center" valign="top" rowspan="1" colspan="1">11.37</td><td align="center" valign="top" rowspan="1" colspan="1">0.0023</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">0.3013</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cell&#x02010;cell adherens junction</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">13</td><td align="center" valign="top" rowspan="1" colspan="1">1.82</td><td align="center" valign="top" rowspan="1" colspan="1">20.44</td><td align="center" valign="top" rowspan="1" colspan="1">0.0042</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">0.3704</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Mitochondrial permeability transition pore complex</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">0.91</td><td align="center" valign="top" rowspan="1" colspan="1">132.29</td><td align="center" valign="top" rowspan="1" colspan="1">0.0076</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">0.3704</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Collagen type II</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">0.91</td><td align="center" valign="top" rowspan="1" colspan="1">132.29</td><td align="center" valign="top" rowspan="1" colspan="1">0.0076</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">0.3704</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Isoamylase complex</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">0.91</td><td align="center" valign="top" rowspan="1" colspan="1">132.29</td><td align="center" valign="top" rowspan="1" colspan="1">0.0076</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">0.3704</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Molecular function</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Chaperone activity</td><td align="center" valign="top" rowspan="1" colspan="1">6</td><td align="center" valign="top" rowspan="1" colspan="1">126</td><td align="center" valign="top" rowspan="1" colspan="1">5.08</td><td align="center" valign="top" rowspan="1" colspan="1">7.33</td><td align="center" valign="top" rowspan="1" colspan="1">0.0002</td><td align="center" valign="top" rowspan="1" colspan="1">0.0392</td><td align="center" valign="top" rowspan="1" colspan="1">0.0392</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Extracellular matrix structural constituent</td><td align="center" valign="top" rowspan="1" colspan="1">6</td><td align="center" valign="top" rowspan="1" colspan="1">166</td><td align="center" valign="top" rowspan="1" colspan="1">5.08</td><td align="center" valign="top" rowspan="1" colspan="1">5.56</td><td align="center" valign="top" rowspan="1" colspan="1">0.0008</td><td align="center" valign="top" rowspan="1" colspan="1">0.1709</td><td align="center" valign="top" rowspan="1" colspan="1">0.0854</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Hydrolase activity</td><td align="center" valign="top" rowspan="1" colspan="1">5</td><td align="center" valign="top" rowspan="1" colspan="1">203</td><td align="center" valign="top" rowspan="1" colspan="1">4.24</td><td align="center" valign="top" rowspan="1" colspan="1">3.79</td><td align="center" valign="top" rowspan="1" colspan="1">0.0106</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">0.7869</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Structural constituent of ribosome</td><td align="center" valign="top" rowspan="1" colspan="1">4</td><td align="center" valign="top" rowspan="1" colspan="1">152</td><td align="center" valign="top" rowspan="1" colspan="1">3.39</td><td align="center" valign="top" rowspan="1" colspan="1">4.05</td><td align="center" valign="top" rowspan="1" colspan="1">0.0175</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">0.7869</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Nucleotide binding</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">0.85</td><td align="center" valign="top" rowspan="1" colspan="1">51.54</td><td align="center" valign="top" rowspan="1" colspan="1">0.0194</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">0.7869</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Oxidoreductase activity</td><td align="center" valign="top" rowspan="1" colspan="1">4</td><td align="center" valign="top" rowspan="1" colspan="1">161</td><td align="center" valign="top" rowspan="1" colspan="1">3.39</td><td align="center" valign="top" rowspan="1" colspan="1">3.83</td><td align="center" valign="top" rowspan="1" colspan="1">0.0211</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">0.7869</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Protein serine/threonine phosphatase activity</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">44</td><td align="center" valign="top" rowspan="1" colspan="1">1.69</td><td align="center" valign="top" rowspan="1" colspan="1">7.01</td><td align="center" valign="top" rowspan="1" colspan="1">0.0333</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Growth factor binding</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">8</td><td align="center" valign="top" rowspan="1" colspan="1">0.85</td><td align="center" valign="top" rowspan="1" colspan="1">19.37</td><td align="center" valign="top" rowspan="1" colspan="1">0.0509</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Biological process</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Energy pathways</td><td align="center" valign="top" rowspan="1" colspan="1">22</td><td align="center" valign="top" rowspan="1" colspan="1">1633</td><td align="center" valign="top" rowspan="1" colspan="1">18.64</td><td align="center" valign="top" rowspan="1" colspan="1">2.07</td><td align="center" valign="top" rowspan="1" colspan="1">0.0008</td><td align="center" valign="top" rowspan="1" colspan="1">0.1396</td><td align="center" valign="top" rowspan="1" colspan="1">0.1038</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Metabolism</td><td align="center" valign="top" rowspan="1" colspan="1">22</td><td align="center" valign="top" rowspan="1" colspan="1">1683</td><td align="center" valign="top" rowspan="1" colspan="1">18.64</td><td align="center" valign="top" rowspan="1" colspan="1">2.01</td><td align="center" valign="top" rowspan="1" colspan="1">0.0012</td><td align="center" valign="top" rowspan="1" colspan="1">0.2077</td><td align="center" valign="top" rowspan="1" colspan="1">0.1038</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Protein metabolism</td><td align="center" valign="top" rowspan="1" colspan="1">17</td><td align="center" valign="top" rowspan="1" colspan="1">1323</td><td align="center" valign="top" rowspan="1" colspan="1">14.41</td><td align="center" valign="top" rowspan="1" colspan="1">1.97</td><td align="center" valign="top" rowspan="1" colspan="1">0.0053</td><td align="center" valign="top" rowspan="1" colspan="1">0.9431</td><td align="center" valign="top" rowspan="1" colspan="1">0.3144</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Regulation of endocytosis</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">4</td><td align="center" valign="top" rowspan="1" colspan="1">0.85</td><td align="center" valign="top" rowspan="1" colspan="1">38.68</td><td align="center" valign="top" rowspan="1" colspan="1">0.0258</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cell growth and/or maintenance</td><td align="center" valign="top" rowspan="1" colspan="1">13</td><td align="center" valign="top" rowspan="1" colspan="1">1125</td><td align="center" valign="top" rowspan="1" colspan="1">11.02</td><td align="center" valign="top" rowspan="1" colspan="1">1.78</td><td align="center" valign="top" rowspan="1" colspan="1">0.0313</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">1</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Carbohydrate metabolism</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">8</td><td align="center" valign="top" rowspan="1" colspan="1">0.85</td><td align="center" valign="top" rowspan="1" colspan="1">19.37</td><td align="center" valign="top" rowspan="1" colspan="1">0.0509</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">1</td></tr></tbody></table><table-wrap-foot><fn id="cre270103-tbl4-note-0001"><p>Abbreviation: BH, Benjamini&#x02013;Hochberg.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap></sec><sec id="cre270103-sec-0160"><label>3.3</label><title>Proteins in GF&#x02010;Perio Secretomes Related to Wound Healing and Bone Regeneration</title><p>Several key mediators of wound healing were detected in GF&#x02010;perio CM, such as growth factors [transforming growth factor beta (TGF&#x003b2;), bone morphogenic protein (BMP), vascular endothelial growth factor (VEGF), insulin&#x02010;like growth factor (IGF), and platelet&#x02010;derived growth factor (PDGF) family proteins], cell adhesion molecules [cadherins (CDH2, CDH6, CDH11, CDH13), tetranectin (CLEC3B), fibronectin (FN1), integrins, etc.], and ECM proteins [collagens (COL), collagenases/metalloproteinases (MMP), tissue inhibitors of metalloproteinases (TIMP), etc.] (Tables&#x000a0;<xref rid="cre270103-tbl-0005" ref-type="table">5</xref> and&#x000a0;<xref rid="cre270103-suppl-0002" ref-type="supplementary-material">S2</xref>). Moreover, among the top 10 DEPs in GF&#x02010;perio were important cell adhesion molecules, such as cadherin&#x02010;5/VE&#x02010;cadherin (CDH5), tetranectin (CLEC3B), and ECM proteins, such as SPARC&#x02010;like protein&#x02010;1 (SPARCL1) (Table&#x000a0;<xref rid="cre270103-tbl-0001" ref-type="table">1</xref>).</p><table-wrap position="float" id="cre270103-tbl-0005" content-type="Table"><label>Table 5</label><caption><p>Selected proteins related to wound healing identified in GF&#x02010;perio CM.</p></caption><table frame="hsides" rules="groups"><col align="left" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col align="center" style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000" valign="bottom"><th align="left" valign="bottom" rowspan="1" colspan="1">Category</th><th align="center" valign="bottom" rowspan="1" colspan="1">Proteins</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Growth factor</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">TGF&#x02010;family (TGFB1, TGFB2, TGFBI, TGFBR3, TGFBR2, LTBP1, LTBP2, LTBP4), BMP1, FGFRL1, PDGF&#x02010;family (PDGFRA, PDGFRB), EGF&#x02010;family (EGFR, EPS15, EPS15L1), IGF&#x02010;family (IGF1, IGF2, IGFBP2, IGF2R, IGFBP3, IGFBP4, IGFBP5, IGFBP6, IGFBP7), MEGF&#x02010;family (MEGF6, MEGF8), VEGF&#x02010;family (FLT1, FLT4), AHNAK, HDGF, CSF1, EFEMP2, NEGR1, GRB2, SDF2, SDF2L1, EFEMP1, MYDGF, PDGFD, NCAM1, CXCL12, MET, MEGF10, KITLG, NPDC1, NES, PDGFC<xref rid="cre270103-tbl5-note-0002" ref-type="table-fn">*</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Angiogenesis</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">ANGPTL2, VEGFC, ANGPTL4, ACE, EF1, VEGFA, FLT4, ESM1, PROCR</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Extracellular matrix</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">Collagens (COL1A1, COL1A2, COL3A1, COLGALT1), COMP, CSPG4, POSTN, CEMIP, CRTAP, CTSL, ECM1, SPARC, SPARCL1, MMP&#x02010;family (MMP1, MMP14, MMP2<xref rid="cre270103-tbl5-note-0002" ref-type="table-fn">*</xref>, MMP3), TIMP&#x02010;family (TIMP1, TIMP2, TIMP3), MXRA5, MXRA8, COL4A1<xref rid="cre270103-tbl5-note-0002" ref-type="table-fn">*</xref>, COL18A1<xref rid="cre270103-tbl5-note-0002" ref-type="table-fn">*</xref>, COL2A1<xref rid="cre270103-tbl5-note-0002" ref-type="table-fn">*</xref>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Inflammation</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">TNF&#x02010;family (TNFAIP6, TNFRSF12A, TNFRSF1A, TNFRSF10B, TNFRSF11B) CCN&#x02010;family (CCN1, CCN2, CCN3), CLEC11A, ROCK2, RHOA, IL&#x02010;family (IL1RAP, IL6ST, ILF2), PTGES3, CCL2/MCP1, CTSK, PTGFRN, IKBKG, NFATC4</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">
<bold>Cell adhesion</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">Cadherins (CDH2, CDH6, CDH11, CDH13), CLEC3B, PLEC, FN1, VIM, VCL, ITGBL1, Integrins (ITGB1, ITGA3), Laminins (LAMC1, LAMA4, LAMB1, LAMB2, LAMA5, LAMA2, LAMA3), NLGN2<xref rid="cre270103-tbl5-note-0002" ref-type="table-fn">*</xref>
</td></tr></tbody></table><table-wrap-foot><fn id="cre270103-tbl5-note-0001"><p>Full names of proteins are provided in Table&#x000a0;<xref rid="cre270103-suppl-0002" ref-type="supplementary-material">S2</xref>.</p></fn><fn id="cre270103-tbl5-note-0002"><label>*</label><p>Proteins detected exclusively in GF&#x02010;perio CM.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &#x00026; Sons, Ltd.</copyright-holder></permissions></table-wrap><p>While a majority of the relevant wound healing&#x02010;related proteins were identified in both GF&#x02010;perio and GF&#x02010;healthy CM, some differences were observed between the groups among the exclusive proteins (Table&#x000a0;<xref rid="cre270103-suppl-0002" ref-type="supplementary-material">S3</xref>). For example, certain growth factors [e.g., platelet&#x02010;derived growth factor C (PDGFC), neuroligin&#x02010;2 (NLGN2)] were only detected in GF&#x02010;perio CM, while others [platelet&#x02010;derived growth factor receptor&#x02010;like protein (PDGFRL), fibroblast growth factor&#x02010;7 (FGF7), hepatoma&#x02010;derived growth factor&#x02010;related protein&#x02010;3 (HDGFL3), vascular endothelial growth factor receptor&#x02010;2 (KDR)] were only detected in the healthy reference group.</p><p>To validate the LC&#x02010;MS data, a multiplex immunoassay of bone&#x02010;related cytokines was used. Six of the included cytokines revealed consistent values for all tested samples; these included proteins related to the inflammation [interleukins (IL6, IL8)], cell proliferation [fibroblast growth factor&#x02010;2 (FGF2), monocyte chemoattractant protein&#x02010;1 (MCP1)/CC motif chemokine ligand&#x02010;2 (CCL2), and ECM components [matrix metallopeptidase&#x02010;2 (MMP2), osteoactivin/transmembrane glycoprotein NMB (GPNMB)]. Compared to the healthy reference group, GF&#x02010;perio CM revealed trends for increased detection of all but one cytokine (GPNMB), although none of these reached statistical significance (<italic toggle="yes">p</italic>&#x02009;&#x0003e;&#x02009;0.05 for all) (Figure&#x000a0;<xref rid="cre270103-fig-0002" ref-type="fig">2</xref>).</p><fig position="float" fig-type="Figure" id="cre270103-fig-0002"><label>Figure 2</label><caption><p>Multiplex assay. Levels of cytokines detected in GF&#x02010;perio CM relative to the healthy reference group. Data represent means; each point represents an individual GF&#x02010;perio donor. No significant differences were detected for any of the cytokines (Students' <italic toggle="yes">t&#x02010;</italic>test; <italic toggle="yes">p</italic>&#x02009;&#x0003e;&#x02009;0.05 for all).</p></caption><graphic xlink:href="CRE2-11-e70103-g001" position="anchor" id="jats-graphic-3"/></fig></sec></sec><sec sec-type="discussion" id="cre270103-sec-0170"><label>4</label><title>Discussion</title><p>The objective of the present study was to characterize the secretomes of GF&#x02010;perio using LC&#x02010;MS/MS. Several growth factors, cytokines, chemokines, and extracellular matrix proteins important for wound healing and regeneration were identified in GF&#x02010;perio CM. The presence of selected bone&#x02010;related proteins was confirmed via an immunoassay. Relative to a reference group of healthy GF, significant enrichment of specific protein categories, particularly exosomes, was observed in GF&#x02010;perio CM. Thus, the present findings offer relevant insights on the secretomes of GF&#x02010;perio with implications for use in regenerative therapies.</p><p>Previous studies have characterized the proteomic profiles of GF (cell&#x02010;lysates) (McKnight et al.&#x000a0;<xref rid="cre270103-bib-0033" ref-type="bibr">2014</xref>) and their CM (secretomes) (Onyedibe et al.&#x000a0;<xref rid="cre270103-bib-0034" ref-type="bibr">2022</xref>) from healthy donors. Recently, Bao et al (Bao et al.&#x000a0;<xref rid="cre270103-bib-0004" ref-type="bibr">2020</xref>). compared the protein profiles of in situ gingival biopsies harvested from healthy and periodontally&#x02010;diseased sites. Consistent with our findings, the authors reported similar global profiles between healthy and diseased sites and a similar number of DEPs (<italic toggle="yes">n</italic>&#x02009;=&#x02009;69), mostly detected in the diseased sites (Bao et al.&#x000a0;<xref rid="cre270103-bib-0004" ref-type="bibr">2020</xref>). Functional profiling also revealed enrichment of similar GO categories and components as in the present study. These consistent findings are especially interesting given the differences in study designs. While in the former study (Bao et al.&#x000a0;<xref rid="cre270103-bib-0004" ref-type="bibr">2020</xref>) proteins were analyzed directly from in situ harvested gingival tissues, the secreted proteins in the present study were obtained from in vitro cultured GF. While it may be argued that the in vitro culture process introduced some modifications in the properties and secretory profiles of the cells, based on the above findings, it may be speculated that the inherent (in vivo) secretory profiles of GF are largely unaltered following in vitro culture. Nevertheless, the present study findings are relevant for regenerative therapy protocols where secretomes/CM are produced via ex vivo culture expansion of cells harvested from tissue biopsies.</p><p>In the context of wound healing, GF&#x02010;perio CM revealed the presence of several proteins related to the different phases (Table&#x000a0;<xref rid="cre270103-tbl-0005" ref-type="table">5</xref>). Wound healing is a complex and dynamic process comprising four interconnected phases, that is, hemostasis, inflammation, proliferation/angiogenesis, and ECM synthesis/remodeling (Velnar et al.&#x000a0;<xref rid="cre270103-bib-0048" ref-type="bibr">2009</xref>). Of particular interest was the detection of several growth factors of the TGF&#x003b2;&#x02010;, BMP&#x02010;, VEGF&#x02010;, IGF&#x02010;, PDGF&#x02010;, and CCN&#x02010;family, important for cell proliferation and differentiation (Barrientos et al.&#x000a0;<xref rid="cre270103-bib-0005" ref-type="bibr">2008</xref>; Linkhart et al.&#x000a0;<xref rid="cre270103-bib-0027" ref-type="bibr">1996</xref>). Moreover, relative to the reference group (GF&#x02010;healthy CM), a number of cell adhesion molecules (CDH5, CLEC3B) and ECM proteins (SPARCL1) were significantly overexpressed in GF&#x02010;perio CM. Functional analysis of DEPs also revealed a significant enrichment of proteins related to exosomes in GF&#x02010;perio CM. This is of particular interest, given the emerging role of EVs in wound healing (Lu et al.&#x000a0;<xref rid="cre270103-bib-0029" ref-type="bibr">2022</xref>) and in periodontal and bone regenerative therapies (Wang, Chen, et al.&#x000a0;<xref rid="cre270103-bib-0050" ref-type="bibr">2022</xref>; Wang, Cao, et al.&#x000a0;<xref rid="cre270103-bib-0049" ref-type="bibr">2022</xref>). In addition to soluble proteins, GF is known to release EVs, including exosomes, to mediate their paracrine functions (Yin et al.&#x000a0;<xref rid="cre270103-bib-0053" ref-type="bibr">2021</xref>; Zhuang and Zhou&#x000a0;<xref rid="cre270103-bib-0054" ref-type="bibr">2020</xref>; Sun et al.&#x000a0;<xref rid="cre270103-bib-0046" ref-type="bibr">2022</xref>). A post&#x02010;hoc analysis confirmed that at least 85 of the &#x0201c;top 100 EV proteins&#x0201d; according to Vesiclepedia (Chitti et al.&#x000a0;<xref rid="cre270103-bib-0013" ref-type="bibr">2024</xref>) were present in GF&#x02010;perio CM (Table&#x000a0;<xref rid="cre270103-suppl-0002" ref-type="supplementary-material">S4</xref>). In light of these data, further characterization of the EV&#x02010;component of GF&#x02010;perio CM and its effects on target cells is warranted.</p><p>It is relevant to discuss the present findings in the context of the defining clinical factor characterizing GF&#x02010;perio, that is, inflammation. These cells were obtained from the periodontally affected teeth of patients undergoing surgery. According to current guidelines (Sanz et al.&#x000a0;<xref rid="cre270103-bib-0042" ref-type="bibr">2020</xref>), these teeth were assigned to a surgical intervention since they presented with persisting signs of inflammation (PPD&#x02009;&#x0003e;&#x02009;5&#x02009;mm and/or BoP), despite previous nonsurgical instrumentation and adequate plaque control. Since GF were isolated from connective tissue biopsies collected during access flap surgery around periodontally affected teeth, it is reasonable to assume that these cells were obtained from a microenvironment characterized by, among other things, inflammation and hypoxia (Celik and Kantarci&#x000a0;<xref rid="cre270103-bib-0010" ref-type="bibr">2021</xref>). In context, inflammation (via cytokine stimulation) and hypoxia are among the most commonly reported &#x0201c;preconditioning&#x0201d; strategies to enhance the therapeutic efficacy of cells and their secretomes (Chen et al.&#x000a0;<xref rid="cre270103-bib-0011" ref-type="bibr">2022</xref>; Hertel et al.&#x000a0;<xref rid="cre270103-bib-0018" ref-type="bibr">2022</xref>; Pulido&#x02010;Escribano et al.&#x000a0;<xref rid="cre270103-bib-0039" ref-type="bibr">2022</xref>). The mechanisms implicated in these effects have included, in the case of hypoxia, enhanced stemness and differentiation potential, and, in the case of cytokine stimulation, a shift towards a more &#x0201c;anti&#x02010;inflammatory phenotype&#x0201d; and enhance immune modulation (Chen et al.&#x000a0;<xref rid="cre270103-bib-0011" ref-type="bibr">2022</xref>). Indeed, these changes are also reflected in the secretomes and EVs of the preconditioned cells (Long and Wang&#x000a0;<xref rid="cre270103-bib-0028" ref-type="bibr">2024</xref>). Whether the molecular findings of the present study, for example, enrichment of exosomes in GF&#x02010;perio CM, could be partly attributed to some form of inflammatory &#x0201c;preconditioning,&#x0201d; is presently speculative and requires further investigation.</p><p>It is also relevant to discuss the present findings in the context of the evidence of fibroblast heterogeneity in the periodontium. The relevance of different fibroblast subpopulations (based on lineage, development, differentiation potential, response to stimuli, etc.) has been extensively discussed in the context of both periodontal health and disease (McCulloch and Bordin&#x000a0;<xref rid="cre270103-bib-0032" ref-type="bibr">1991</xref>; Phipps et al.&#x000a0;<xref rid="cre270103-bib-0037" ref-type="bibr">1997</xref>; Lekic et al.&#x000a0;<xref rid="cre270103-bib-0024" ref-type="bibr">1997</xref>). Such heterogeneity has been reported not only between fibroblasts from different tissue components (e.g., PDL vs. gingiva) but also within the same tissue. In the gingiva, different fibroblast subtypes have been identified, with additional differences being detected in healthy and diseased tissues (Hakkinen and Larjava&#x000a0;<xref rid="cre270103-bib-0015" ref-type="bibr">1992</xref>; Hassell and Stanek&#x000a0;<xref rid="cre270103-bib-0017" ref-type="bibr">1983</xref>). While a majority of the fibroblast subtypes have been characterized based on in vitro differences in morphology, proliferation rate and differentiation potential, some evidence also suggests that these subtypes may differ in their secretory properties (Lekic et al.&#x000a0;<xref rid="cre270103-bib-0024" ref-type="bibr">1997</xref>). Thus, certain fibroblast subtypes may dominate during specific phases of a healthy or disease state, thereby influencing the secretory profile. However, reliable identification of these subtypes in vivo has been limited by the lack of highly specific surface markers which could allow their differential detection. Using emerging techniques (e.g., single&#x02010;cell analysis), future studies may reveal distinct fibroblast subpopulations in the gingiva (in health and disease) with corresponding differences in secretory profiles.</p><p>With regard to the methodology, a systematic and comprehensive bioinformatic approach was used to analyze the LC&#x02010;MS/MS data in the present study. Moreover, proteomic findings were validated using a more conventional ELISA&#x02010;based immunoassay. Nevertheless, some study limitations must be acknowledged. Firstly, the number of GF donors (<italic toggle="yes">n</italic>&#x02009;=&#x02009;6) was limited. Although recent comparative studies of proteomic data have reported similar donor numbers (Lertruangpanya et al.&#x000a0;<xref rid="cre270103-bib-0025" ref-type="bibr">2024</xref>; Chen et al.&#x000a0;<xref rid="cre270103-bib-0012" ref-type="bibr">2019</xref>; Shin et al.&#x000a0;<xref rid="cre270103-bib-0045" ref-type="bibr">2021</xref>), inclusion of additional donors may have provided a clearer picture of donor&#x02010;related variations in GF&#x02010;perio secretomes. Moreover, the &#x0201c;healthy&#x0201d; reference GFs were obtained from a biobank of previously isolated cells from clinically healthy gingival tissues and not from age&#x02010; and gender&#x02010;matched controls to the GF&#x02010;perio donors. While &#x0201c;donor&#x02010;matched&#x0201d; (same patients) cell harvesting may have reduced some potential bias, the reliability of obtaining truly &#x0201c;healthy&#x0201d; tissue controls in periodontitis patients, especially severe&#x02010;to&#x02010;advanced cases (Stage III&#x02013;IV) requiring surgery, may be questioned (Bao et al.&#x000a0;<xref rid="cre270103-bib-0004" ref-type="bibr">2020</xref>). Additionally, no &#x0201c;functional&#x0201d; assay, for example, in vitro wound healing, gene expression, was performed to investigate the effects of GF&#x02010;perio CM on relevant target cells, for example, osteoblasts or PDL fibroblasts. A bioassay (e.g., RNA&#x02010;sequencing) to detect differential effects of GF&#x02010;perio and GF&#x02010;healthy secretomes on such target cells would be interesting for future research. Finally, GF in the present study were cultured in vitro in plastic adherent and serum&#x02010;supplemented conditions, which may not reflect the true in vivo scenario but represents a more clinically relevant approach since secretomes for clinical applications are produced from ex vivo culture&#x02010;expanded cells under GMP conditions (Sagaradze et al.&#x000a0;<xref rid="cre270103-bib-0040" ref-type="bibr">2019</xref>).</p></sec><sec sec-type="conclusions" id="cre270103-sec-0180"><label>5</label><title>Conclusions</title><p>Within its limitations, the present study demonstrates that, in addition to several proteins important for wound healing and bone regeneration, the secretome of GF from periodontally diseased tissues is significantly enriched for proteins related to exosomes. Since gingival biopsies can be easily obtained during periodontal surgery, the secretomes of GF&#x02010;perio represent a promising biological therapy for regenerative applications. Further investigation of their potency, along with efficacy testing in relevant in vitro and in vivo models, is warranted.</p></sec><sec id="cre270103-sec-0190"><title>Author Contributions</title><p>Siddharth Shanbhag, Dagmar Foss&#x000e5; Bun&#x000e6;s and Kamal Mustafa conceived and designed the study. Anne Kari Smed&#x000e5;s, Lovise Gangeskar Paris, and Siddharth Shanbhag performed the experiments. Anne Kari Smed&#x000e5;s, Lovise Gangeskar Paris, Dagmar Foss&#x000e5; Bun&#x000e6;s, Niyaz Al&#x02010;Sharabi, and Siddharth Shanbhag contributed to data analysis. All authors contributed to the interpretation of data and writing. All authors read and approved the final manuscript.</p></sec><sec id="cre270103-sec-0210"><title>Ethics Statement</title><p>The use of human cells and tissues was approved by the Regional Committees for Medical Research Ethics (REK) in Norway (2011/1516/REK and 2016/1267/REK&#x02010;nord).</p></sec><sec id="cre270103-sec-0220"><title>Consent</title><p>The authors have nothing to report.</p></sec><sec sec-type="COI-statement" id="cre270103-sec-0230"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="cre270103-suppl-0001" position="float" content-type="local-data"><caption><p>Supporting information.</p></caption><media xlink:href="CRE2-11-e70103-s001.docx"/></supplementary-material><supplementary-material id="cre270103-suppl-0002" position="float" content-type="local-data"><caption><p>Supporting information.</p></caption><media xlink:href="CRE2-11-e70103-s002.xlsx"/></supplementary-material></sec></body><back><ack id="cre270103-sec-0200"><title>Acknowledgments</title><p>This work was supported by Helse Vest Research Funding, Norway (F&#x02010;12124) and &#x0201c;Stiftelsen til tannlegevitenskapens fremme,&#x0201d; Norway. The funding bodies played no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.</p></ack><sec sec-type="data-availability" id="cre270103-sec-0250"><title>Data Availability Statement</title><p>Additional data are included in the Supporting data file and can be made available by the authors upon request. The mass spectrometry proteomics data have been deposited to the Proteome&#x02010;Xchange Consortium via the PRIDE partner repository (<ext-link xlink:href="https://www.ebi.ac.uk/pride/" ext-link-type="uri" specific-use="software is-supplemented-by">https://www.ebi.ac.uk/pride/</ext-link>) with the data set identifier PXD054664.</p></sec><ref-list content-type="cited-references" id="cre270103-bibl-0001"><title>References</title><ref id="cre270103-bib-0001"><mixed-citation publication-type="journal" id="cre270103-cit-0001">
<string-name>
<surname>Aaseb&#x000f8;</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<given-names>A. K.</given-names>
<surname>Brenner</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Hernandez&#x02010;Valladares</surname>
</string-name>, et al. <year>2021</year>. &#x0201c;<article-title>Proteomic Comparison of Bone Marrow Derived Osteoblasts and Mesenchymal Stem Cells</article-title>.&#x0201d; <source>International Journal of Molecular Sciences</source>
<volume>22</volume>, no. <issue>11</issue>: <elocation-id>5665</elocation-id>. <pub-id pub-id-type="doi">10.3390/ijms22115665</pub-id>.<pub-id pub-id-type="pmid">34073480</pub-id>
</mixed-citation></ref><ref id="cre270103-bib-0002"><mixed-citation publication-type="journal" id="cre270103-cit-0002">
<string-name>
<surname>Ahangar</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<given-names>S. J.</given-names>
<surname>Mills</surname>
</string-name>, <string-name>
<given-names>L. E.</given-names>
<surname>Smith</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Gronthos</surname>
</string-name>, and <string-name>
<given-names>A. J.</given-names>
<surname>Cowin</surname>
</string-name>. <year>2020</year>. &#x0201c;<article-title>Human Gingival Fibroblast Secretome Accelerates Wound Healing Through Anti&#x02010;Inflammatory and Pro&#x02010;Angiogenic Mechanisms</article-title>.&#x0201d; <source>NPJ Regenerative Medicine</source>
<volume>5</volume>: <fpage>24</fpage>, 12/16. <pub-id pub-id-type="doi">10.1038/s41536-020-00109-9</pub-id>.<pub-id pub-id-type="pmid">33303754</pub-id>
</mixed-citation></ref><ref id="cre270103-bib-0003"><mixed-citation publication-type="journal" id="cre270103-cit-0003">
<string-name>
<surname>Baek</surname>, <given-names>K. J.</given-names>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Choi</surname>
</string-name>, and <string-name>
<given-names>S.</given-names>
<surname>Ji</surname>
</string-name>. <year>2013</year>. &#x0201c;<article-title>Gingival Fibroblasts From Periodontitis Patients Exhibit Inflammatory Characteristics In Vitro</article-title>.&#x0201d; <source>Archives of Oral Biology</source>
<volume>58</volume>, no. <issue>10</issue>: <fpage>1282</fpage>&#x02013;<lpage>1292</lpage>. <pub-id pub-id-type="doi">10.1016/j.archoralbio.2013.07.007</pub-id>.<pub-id pub-id-type="pmid">24011303</pub-id>
</mixed-citation></ref><ref id="cre270103-bib-0004"><mixed-citation publication-type="journal" id="cre270103-cit-0004">
<string-name>
<surname>Bao</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<given-names>X.</given-names>
<surname>Li</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Poveda</surname>
</string-name>, et al. <year>2020</year>. &#x0201c;<article-title>Proteome and Microbiome Mapping of Human Gingival Tissue in Health and Disease</article-title>.&#x0201d; <source>Frontiers in Cellular and Infection Microbiology</source>
<volume>10</volume>: <elocation-id>588155</elocation-id>. <pub-id pub-id-type="doi">10.3389/fcimb.2020.588155</pub-id>.<pub-id pub-id-type="pmid">33117738</pub-id>
</mixed-citation></ref><ref id="cre270103-bib-0005"><mixed-citation publication-type="journal" id="cre270103-cit-0005">
<string-name>
<surname>Barrientos</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<given-names>O.</given-names>
<surname>Stojadinovic</surname>
</string-name>, <string-name>
<given-names>M. S.</given-names>
<surname>Golinko</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Brem</surname>
</string-name>, and <string-name>
<given-names>M.</given-names>
<surname>Tomic&#x02010;Canic</surname>
</string-name>. <year>2008</year>. &#x0201c;<article-title>Perspective Article: Growth Factors and Cytokines in Wound Healing</article-title>.&#x0201d; <source>Wound Repair and Regeneration</source>
<volume>16</volume>, no. <issue>5</issue>: <fpage>585</fpage>&#x02013;<lpage>601</lpage>. <pub-id pub-id-type="doi">10.1111/j.1524-475X.2008.00410.x</pub-id>.<pub-id pub-id-type="pmid">19128254</pub-id>
</mixed-citation></ref><ref id="cre270103-bib-0006"><mixed-citation publication-type="journal" id="cre270103-cit-0006">
<string-name>
<surname>Bartold</surname>, <given-names>P. M.</given-names>
</string-name>, and <string-name>
<given-names>R. C.</given-names>
<surname>Page</surname>
</string-name>. <year>1986a</year>. &#x0201c;<article-title>Hyaluronic Acid Synthesized by Fibroblasts Cultured From Normal and Chronically Inflamed Human Gingivae</article-title>.&#x0201d; <source>Collagen and Related Research</source>
<volume>6</volume>, no. <issue>4</issue>: <fpage>365</fpage>&#x02013;<lpage>378</lpage>. <pub-id pub-id-type="doi">10.1016/S0174-173X(86)80006-1</pub-id>.<pub-id pub-id-type="pmid">3816141</pub-id>
</mixed-citation></ref><ref id="cre270103-bib-0007"><mixed-citation publication-type="journal" id="cre270103-cit-0007">
<string-name>
<surname>Bartold</surname>, <given-names>P. M.</given-names>
</string-name>, and <string-name>
<given-names>R. C.</given-names>
<surname>Page</surname>
</string-name>. <year>1986b</year>. &#x0201c;<article-title>Proteoglycans Synthesized by Cultured Fibroblasts Derived From Normal and Inflamed Human Gingiva</article-title>.&#x0201d; <source>In Vitro Cellular and Developmental Biology</source>
<volume>22</volume>, no. <issue>7</issue>: <fpage>407</fpage>&#x02013;<lpage>417</lpage>. <pub-id pub-id-type="doi">10.1007/bf02623531</pub-id>.<pub-id pub-id-type="pmid">3733638</pub-id>
</mixed-citation></ref><ref id="cre270103-bib-0008"><mixed-citation publication-type="journal" id="cre270103-cit-0008">
<string-name>
<surname>Beki&#x00107;</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Radanovi&#x00107;</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>&#x00110;oki&#x00107;</surname>
</string-name>, et al. <year>2022</year>. &#x0201c;<article-title>Mesenchymal Stromal Cells From Healthy and Inflamed Human Gingiva Respond Differently to Porphyromonas Gingivalis</article-title>.&#x0201d; <source>International Journal of Molecular Sciences</source>
<volume>23</volume>, no. <issue>7</issue>: <elocation-id>3510</elocation-id>. <pub-id pub-id-type="doi">10.3390/ijms23073510</pub-id>.<pub-id pub-id-type="pmid">35408871</pub-id>
</mixed-citation></ref><ref id="cre270103-bib-0010"><mixed-citation publication-type="journal" id="cre270103-cit-0010">
<string-name>
<surname>Celik</surname>, <given-names>D.</given-names>
</string-name>, and <string-name>
<given-names>A.</given-names>
<surname>Kantarci</surname>
</string-name>. <year>2021</year>. &#x0201c;<article-title>Vascular Changes and Hypoxia in Periodontal Disease as a Link to Systemic Complications</article-title>.&#x0201d; <source>Pathogens</source>
<volume>10</volume>, no. <issue>10</issue>: <elocation-id>1280</elocation-id>. <pub-id pub-id-type="doi">10.3390/pathogens10101280</pub-id>.<pub-id pub-id-type="pmid">34684229</pub-id>
</mixed-citation></ref><ref id="cre270103-bib-0011"><mixed-citation publication-type="journal" id="cre270103-cit-0011">
<string-name>
<surname>Chen</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Sun</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Qian</surname>
</string-name>, <string-name>
<given-names>W.</given-names>
<surname>Xu</surname>
</string-name>, and <string-name>
<given-names>J.</given-names>
<surname>Jiang</surname>
</string-name>. <year>2022</year>. &#x0201c;<article-title>Preconditioning and Engineering Strategies for Improving the Efficacy of Mesenchymal Stem Cell&#x02010;Derived Exosomes in Cell&#x02010;Free Therapy</article-title>.&#x0201d; <source>Stem Cells International</source>
<volume>2022</volume>: <fpage>1</fpage>&#x02013;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1155/2022/1779346</pub-id>.</mixed-citation></ref><ref id="cre270103-bib-0012"><mixed-citation publication-type="journal" id="cre270103-cit-0012">
<string-name>
<surname>Chen</surname>, <given-names>Y. T.</given-names>
</string-name>, <string-name>
<given-names>M. J.</given-names>
<surname>Tsai</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Hsieh</surname>
</string-name>, et al. <year>2019</year>. &#x0201c;<article-title>The Superiority of Conditioned Medium Derived From Rapidly Expanded Mesenchymal Stem Cells for Neural Repair</article-title>.&#x0201d; <source>Stem Cell Research &#x00026; Therapy</source>
<volume>10</volume>, no. <issue>1</issue>: <fpage>390</fpage>. <pub-id pub-id-type="doi">10.1186/s13287-019-1491-7</pub-id>.<pub-id pub-id-type="pmid">31842998</pub-id>
</mixed-citation></ref><ref id="cre270103-bib-0013"><mixed-citation publication-type="journal" id="cre270103-cit-0013">
<string-name>
<surname>Chitti</surname>, <given-names>S. V.</given-names>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Gummadi</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Kang</surname>
</string-name>, et al. <year>2024</year>. &#x0201c;<article-title>Vesiclepedia 2024: An Extracellular Vesicles and Extracellular Particles Repository</article-title>.&#x0201d; [In English.] <source>Nucleic Acids Research</source>
<volume>52</volume>, no. <issue>D1</issue>: <fpage>D1694</fpage>&#x02013;<lpage>D1698</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkad1007</pub-id>.<pub-id pub-id-type="pmid">37953359</pub-id>
</mixed-citation></ref><ref id="cre270103-bib-0014"><mixed-citation publication-type="journal" id="cre270103-cit-0014">
<string-name>
<surname>Ge</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<given-names>K. M.</given-names>
<surname>Mrozik</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Menicanin</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Gronthos</surname>
</string-name>, and <string-name>
<given-names>P. M.</given-names>
<surname>Bartold</surname>
</string-name>. <year>2012</year>. &#x0201c;<article-title>Isolation and Characterization of Mesenchymal Stem Cell&#x02010;Like Cells From Healthy and Inflamed Gingival Tissue: Potential Use for Clinical Therapy</article-title>.&#x0201d; <source>Regenerative Medicine</source>
<volume>7</volume>, no. <issue>6</issue>: <fpage>819</fpage>&#x02013;<lpage>832</lpage>. <pub-id pub-id-type="doi">10.2217/rme.12.61</pub-id>.<pub-id pub-id-type="pmid">23164082</pub-id>
</mixed-citation></ref><ref id="cre270103-bib-0015"><mixed-citation publication-type="journal" id="cre270103-cit-0015">
<string-name>
<surname>Hakkinen</surname>, <given-names>L.</given-names>
</string-name>, and <string-name>
<given-names>H.</given-names>
<surname>Larjava</surname>
</string-name>. <year>1992</year>. &#x0201c;<article-title>Characterization of Fibroblast Clones From Periodontal Granulation Tissue In Vitro</article-title>.&#x0201d; <source>Journal of Dental Research</source>
<volume>71</volume>, no. <issue>12</issue>: <fpage>1901</fpage>&#x02013;<lpage>1907</lpage>. <pub-id pub-id-type="doi">10.1177/00220345920710120901</pub-id>.<pub-id pub-id-type="pmid">1452891</pub-id>
</mixed-citation></ref><ref id="cre270103-bib-0016"><mixed-citation publication-type="journal" id="cre270103-cit-0016">
<string-name>
<surname>H&#x000e4;kkinen</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Larjava</surname>
</string-name>, and <string-name>
<given-names>B. P. J.</given-names>
<surname>Fournier</surname>
</string-name>. <year>2014</year>. &#x0201c;<article-title>Distinct Phenotype and Therapeutic Potential of Gingival Fibroblasts</article-title>.&#x0201d; <source>Cytotherapy</source>
<volume>16</volume>, no. <issue>9</issue>: <fpage>1171</fpage>&#x02013;<lpage>1186</lpage>. <pub-id pub-id-type="doi">10.1016/j.jcyt.2014.04.004</pub-id>.<pub-id pub-id-type="pmid">24934304</pub-id>
</mixed-citation></ref><ref id="cre270103-bib-0017"><mixed-citation publication-type="journal" id="cre270103-cit-0017">
<string-name>
<surname>Hassell</surname>, <given-names>T. M.</given-names>
</string-name>, and <string-name>
<given-names>E. J.</given-names>
<surname>Stanek</surname>
<suffix>3rd</suffix>
</string-name>. <year>1983</year>. &#x0201c;<article-title>Evidence That Healthy Human Gingiva Contains Functionally Heterogeneous Fibroblast Subpopulations</article-title>.&#x0201d; <source>Archives of Oral Biology</source>
<volume>28</volume>, no. <issue>7</issue>: <fpage>617</fpage>&#x02013;<lpage>625</lpage>. <pub-id pub-id-type="doi">10.1016/0003-9969(83)90010-9</pub-id>.<pub-id pub-id-type="pmid">6579893</pub-id>
</mixed-citation></ref><ref id="cre270103-bib-0018"><mixed-citation publication-type="journal" id="cre270103-cit-0018">
<string-name>
<surname>Hertel</surname>, <given-names>F. C.</given-names>
</string-name>, <string-name>
<given-names>A. S.</given-names>
<surname>Silva</surname>
</string-name>, <string-name>
<given-names>A. P.</given-names>
<surname>Sabino</surname>
</string-name>, <string-name>
<given-names>F. L.</given-names>
<surname>Valente</surname>
</string-name>, and <string-name>
<given-names>E. C. C.</given-names>
<surname>Reis</surname>
</string-name>. <year>2022</year>. &#x0201c;<article-title>Preconditioning Methods to Improve Mesenchymal Stromal Cell&#x02010;Derived Extracellular Vesicles in Bone Regeneration &#x02013; A Systematic Review</article-title>.&#x0201d; <source>Biology</source>
<volume>11</volume>, no. <issue>5</issue>, May 11: <elocation-id>733</elocation-id>. <pub-id pub-id-type="doi">10.3390/biology11050733</pub-id>.<pub-id pub-id-type="pmid">35625461</pub-id>
</mixed-citation></ref><ref id="cre270103-bib-0019"><mixed-citation publication-type="journal" id="cre270103-cit-0019">
<string-name>
<surname>Hiraki</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Kunimatsu</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Nakajima</surname>
</string-name>, et al. <year>2020</year>. &#x0201c;<article-title>Stem Cell&#x02010;Derived Conditioned Media From Human Exfoliated Deciduous Teeth Promote Bone Regeneration</article-title>.&#x0201d; [In English.] <source>Oral Diseases</source>
<volume>26</volume>, no. <issue>2</issue>: <fpage>381</fpage>&#x02013;<lpage>390</lpage>. <pub-id pub-id-type="doi">10.1111/odi.13244</pub-id>.<pub-id pub-id-type="pmid">31808229</pub-id>
</mixed-citation></ref><ref id="cre270103-bib-0020"><mixed-citation publication-type="journal" id="cre270103-cit-0020">
<string-name>
<surname>Kanda&#x02010;Nakamura</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Izumi</surname>
</string-name>, and <string-name>
<given-names>T.</given-names>
<surname>Sueda</surname>
</string-name>. <year>1996</year>. &#x0201c;<article-title>Increased Expression of Interleukin&#x02010;1 Receptors on Fibroblasts Derived From Inflamed Gingiva</article-title>.&#x0201d; [In English.] <source>Journal of Periodontology</source>
<volume>67</volume>, no. <issue>12</issue>: <fpage>1267</fpage>&#x02013;<lpage>1273</lpage>. <pub-id pub-id-type="doi">10.1902/jop.1996.67.12.1267</pub-id>.<pub-id pub-id-type="pmid">8997672</pub-id>
</mixed-citation></ref><ref id="cre270103-bib-0021"><mixed-citation publication-type="journal" id="cre270103-cit-0021">
<string-name>
<surname>Kang</surname>, <given-names>W.</given-names>
</string-name>, <string-name>
<given-names>Z.</given-names>
<surname>Hu</surname>
</string-name>, and <string-name>
<given-names>S.</given-names>
<surname>Ge</surname>
</string-name>. <year>2016</year>. &#x0201c;<article-title>Healthy and Inflamed Gingival Fibroblasts Differ in Their Inflammatory Response to Porphyromonas Gingivalis Lipopolysaccharide</article-title>.&#x0201d; [In English.] <source>Inflammation</source>
<volume>39</volume>, no. <issue>5</issue>: <fpage>1842</fpage>&#x02013;<lpage>1852</lpage>. <pub-id pub-id-type="doi">10.1007/s10753-016-0421-4</pub-id>.<pub-id pub-id-type="pmid">27525424</pub-id>
</mixed-citation></ref><ref id="cre270103-bib-0022"><mixed-citation publication-type="journal" id="cre270103-cit-0022">
<string-name>
<surname>Kim</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<given-names>A. E.</given-names>
<surname>Lee</surname>
</string-name>, <string-name>
<given-names>Q.</given-names>
<surname>Xu</surname>
</string-name>, <string-name>
<given-names>Q.</given-names>
<surname>Zhang</surname>
</string-name>, and <string-name>
<given-names>A. D.</given-names>
<surname>Le</surname>
</string-name>. <year>2021</year>. &#x0201c;<article-title>Gingiva&#x02010;Derived Mesenchymal Stem Cells: Potential Application in Tissue Engineering and Regenerative Medicine &#x02013; A Comprehensive Review</article-title>.&#x0201d; <source>Frontiers in Immunology</source>
<volume>12</volume>: <elocation-id>667221</elocation-id>. <pub-id pub-id-type="doi">10.3389/fimmu.2021.667221</pub-id>.<pub-id pub-id-type="pmid">33936109</pub-id>
</mixed-citation></ref><ref id="cre270103-bib-0023"><mixed-citation publication-type="journal" id="cre270103-cit-0023">
<string-name>
<surname>Kolberg</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<given-names>U.</given-names>
<surname>Raudvere</surname>
</string-name>, <string-name>
<given-names>I.</given-names>
<surname>Kuzmin</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Adler</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Vilo</surname>
</string-name>, and <string-name>
<given-names>H.</given-names>
<surname>Peterson</surname>
</string-name>. <year>2023</year>. &#x0201c;<article-title>G:Profiler&#x02010;Interoperable Web Service for Functional Enrichment Analysis and Gene Identifier Mapping (2023 Update)</article-title>.&#x0201d; [In English.] <source>Nucleic Acids Research</source>
<volume>51</volume>, no. <issue>W1</issue>: <fpage>W207</fpage>&#x02013;<lpage>W212</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkad347</pub-id>.<pub-id pub-id-type="pmid">37144459</pub-id>
</mixed-citation></ref><ref id="cre270103-bib-0024"><mixed-citation publication-type="journal" id="cre270103-cit-0024">
<string-name>
<surname>Lekic</surname>, <given-names>P. C.</given-names>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Pender</surname>
</string-name>, and <string-name>
<given-names>C. A. G.</given-names>
<surname>McCulloch</surname>
</string-name>. <year>1997</year>. &#x0201c;<article-title>Is Fibroblast Heterogeneity Relevant to the Health, Diseases, and Treatments of Periodontal Tissues?</article-title>&#x0201d; <source>Critical Reviews in Oral Biology &#x00026; Medicine</source>
<volume>8</volume>, no. <issue>3</issue>: <fpage>253</fpage>&#x02013;<lpage>268</lpage>. <pub-id pub-id-type="doi">10.1177/10454411970080030201</pub-id>.<pub-id pub-id-type="pmid">9260043</pub-id>
</mixed-citation></ref><ref id="cre270103-bib-0025"><mixed-citation publication-type="journal" id="cre270103-cit-0025">
<string-name>
<surname>Lertruangpanya</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Roytrakul</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Surarit</surname>
</string-name>, and <string-name>
<given-names>S.</given-names>
<surname>Horsophonphong</surname>
</string-name>. <year>2024</year>. &#x0201c;<article-title>Comparative Proteomic Analysis of Dental Pulp From Supernumerary and Normal Permanent Teeth</article-title>.&#x0201d; <source>Clinical Oral Investigations</source>
<volume>28</volume>, no. <issue>6</issue>: <fpage>321</fpage>. <pub-id pub-id-type="doi">10.1007/s00784-024-05698-z</pub-id>.<pub-id pub-id-type="pmid">38758416</pub-id>
</mixed-citation></ref><ref id="cre270103-bib-0026"><mixed-citation publication-type="journal" id="cre270103-cit-0026">
<string-name>
<surname>Li</surname>, <given-names>X.</given-names>
</string-name>, <string-name>
<given-names>X.</given-names>
<surname>Wang</surname>
</string-name>, and <string-name>
<given-names>Q.&#x02010;X.</given-names>
<surname>Luan</surname>
</string-name>. <year>2021</year>. &#x0201c;<article-title>Hyperresponsiveness of Human Gingival Fibroblasts From Patients With Aggressive Periodontitis Against Bacterial Lipopolysaccharide</article-title>.&#x0201d; <source>Experimental and Therapeutic Medicine</source>
<volume>21</volume>, no. <issue>5</issue>: <fpage>417</fpage>. <pub-id pub-id-type="doi">10.3892/etm.2021.9861</pub-id>.<pub-id pub-id-type="pmid">33747158</pub-id>
</mixed-citation></ref><ref id="cre270103-bib-0027"><mixed-citation publication-type="journal" id="cre270103-cit-0027">
<string-name>
<surname>Linkhart</surname>, <given-names>T. A.</given-names>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Mohan</surname>
</string-name>, and <string-name>
<given-names>D. J.</given-names>
<surname>Baylink</surname>
</string-name>. <year>1996</year>. &#x0201c;<article-title>Growth Factors for Bone Growth and Repair: IGF, TGF&#x003b2; and BMP</article-title>.&#x0201d; <source>Bone</source>
<volume>19</volume>, no. <issue>1 Suppl</issue>: <fpage>S1</fpage>&#x02013;<lpage>S12</lpage>. <pub-id pub-id-type="doi">10.1016/s8756-3282(96)00138-x</pub-id>.</mixed-citation></ref><ref id="cre270103-bib-0028"><mixed-citation publication-type="journal" id="cre270103-cit-0028">
<string-name>
<surname>Long</surname>, <given-names>R.</given-names>
</string-name>, and <string-name>
<given-names>S.</given-names>
<surname>Wang</surname>
</string-name>. <year>2024</year>. &#x0201c;<article-title>Exosomes From Preconditioned Mesenchymal Stem Cells: Tissue Repair and Regeneration</article-title>.&#x0201d; <source>Regenerative Therapy</source>
<volume>25</volume>: <fpage>355</fpage>&#x02013;<lpage>366</lpage>. <pub-id pub-id-type="doi">10.1016/j.reth.2024.01.009</pub-id>.<pub-id pub-id-type="pmid">38374989</pub-id>
</mixed-citation></ref><ref id="cre270103-bib-0029"><mixed-citation publication-type="journal" id="cre270103-cit-0029">
<string-name>
<surname>Lu</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Lu</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Liu</surname>
</string-name>, et al. <year>2022</year>. &#x0201c;<article-title>Native and Engineered Extracellular Vesicles for Wound Healing</article-title>.&#x0201d; <source>Frontiers in Bioengineering and Biotechnology</source>
<volume>10</volume>: <elocation-id>1053217</elocation-id>. <pub-id pub-id-type="doi">10.3389/fbioe.2022.1053217</pub-id>.<pub-id pub-id-type="pmid">36568307</pub-id>
</mixed-citation></ref><ref id="cre270103-bib-0031"><mixed-citation publication-type="journal" id="cre270103-cit-0031">
<string-name>
<surname>Marolt Presen</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Traweger</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Gimona</surname>
</string-name>, and <string-name>
<given-names>H.</given-names>
<surname>Redl</surname>
</string-name>. <year>2019</year>. &#x0201c;<article-title>Mesenchymal Stromal Cell&#x02010;Based Bone Regeneration Therapies: From Cell Transplantation and Tissue Engineering to Therapeutic Secretomes and Extracellular Vesicles</article-title>.&#x0201d; [In English.] <source>Frontiers in Bioengineering and Biotechnology</source>
<volume>7</volume>: <elocation-id>352</elocation-id>. <pub-id pub-id-type="doi">10.3389/fbioe.2019.00352</pub-id>.<pub-id pub-id-type="pmid">31828066</pub-id>
</mixed-citation></ref><ref id="cre270103-bib-0032"><mixed-citation publication-type="journal" id="cre270103-cit-0032">
<string-name>
<surname>McCulloch</surname>, <given-names>C. A. G.</given-names>
</string-name>, and <string-name>
<given-names>S.</given-names>
<surname>Bordin</surname>
</string-name>. <year>1991</year>. &#x0201c;<article-title>Role of Fibroblast Subpopulations in Periodontal Physiology and Pathology</article-title>.&#x0201d; <source>Journal of Periodontal Research</source>
<volume>26</volume>, no. <issue>3</issue> Pt 1: <fpage>144</fpage>&#x02013;<lpage>154</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-0765.1991.tb01638.x</pub-id>.<pub-id pub-id-type="pmid">1830616</pub-id>
</mixed-citation></ref><ref id="cre270103-bib-0033"><mixed-citation publication-type="journal" id="cre270103-cit-0033">
<string-name>
<surname>McKnight</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<given-names>W. P.</given-names>
<surname>Kelsey</surname>
</string-name>, <string-name>
<given-names>D. A.</given-names>
<surname>Hooper</surname>
</string-name>, <string-name>
<given-names>T. C.</given-names>
<surname>Hart</surname>
</string-name>, and <string-name>
<given-names>A.</given-names>
<surname>Mariotti</surname>
</string-name>. <year>2014</year>. &#x0201c;<article-title>Proteomic Analyses of Human Gingival and Periodontal Ligament Fibroblasts</article-title>.&#x0201d; <source>Journal of Periodontology</source>
<volume>85</volume>, no. <issue>6</issue>: <fpage>810</fpage>&#x02013;<lpage>818</lpage>. <pub-id pub-id-type="doi">10.1902/jop.2013.130161</pub-id>.<pub-id pub-id-type="pmid">24171499</pub-id>
</mixed-citation></ref><ref id="cre270103-bib-0034"><mixed-citation publication-type="journal" id="cre270103-cit-0034">
<string-name>
<surname>Onyedibe</surname>, <given-names>K. I.</given-names>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Elmanfi</surname>
</string-name>, <string-name>
<given-names>U. K.</given-names>
<surname>Aryal</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>K&#x000f6;n&#x000f6;nen</surname>
</string-name>, <string-name>
<given-names>U. K.</given-names>
<surname>G&#x000fc;rsoy</surname>
</string-name>, and <string-name>
<given-names>H. O.</given-names>
<surname>Sintim</surname>
</string-name>. <year>2022</year>. &#x0201c;<article-title>Global Proteomics of Fibroblast Cells Treated With Bacterial Cyclic Dinucleotides, c&#x02010;di&#x02010;GMP and c&#x02010;di&#x02010;AMP</article-title>.&#x0201d; [In English.] <source>Journal of Oral Microbiology</source>
<volume>14</volume>, no. <issue>1</issue>: <elocation-id>2003617</elocation-id>. <pub-id pub-id-type="doi">10.1080/20002297.2021.2003617</pub-id>.<pub-id pub-id-type="pmid">34992733</pub-id>
</mixed-citation></ref><ref id="cre270103-bib-0035"><mixed-citation publication-type="journal" id="cre270103-cit-0035">
<string-name>
<surname>Osugi</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<given-names>W.</given-names>
<surname>Katagiri</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Yoshimi</surname>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Inukai</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Hibi</surname>
</string-name>, and <string-name>
<given-names>M.</given-names>
<surname>Ueda</surname>
</string-name>. <year>2012</year>. &#x0201c;<article-title>Conditioned Media From Mesenchymal Stem Cells Enhanced Bone Regeneration in Rat Calvarial Bone Defects</article-title>.&#x0201d; [In English.] <source>Tissue Engineering. Part A</source>
<volume>18</volume>, no. <issue>13&#x02013;14</issue>: <fpage>1479</fpage>&#x02013;<lpage>1489</lpage>. <pub-id pub-id-type="doi">10.1089/ten.TEA.2011.0325</pub-id>.<pub-id pub-id-type="pmid">22443121</pub-id>
</mixed-citation></ref><ref id="cre270103-bib-0036"><mixed-citation publication-type="journal" id="cre270103-cit-0036">
<string-name>
<surname>Pathan</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Keerthikumar</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Ang</surname>
</string-name>, et al. <year>2015</year>. &#x0201c;<article-title>FunRich: An Open Access Standalone Functional Enrichment and Interaction Network Analysis Tool</article-title>.&#x0201d; <source>Proteomics</source>
<volume>15</volume>, no. <issue>15</issue>: <fpage>2597</fpage>&#x02013;<lpage>2601</lpage>. <pub-id pub-id-type="doi">10.1002/pmic.201400515</pub-id>.<pub-id pub-id-type="pmid">25921073</pub-id>
</mixed-citation></ref><ref id="cre270103-bib-0037"><mixed-citation publication-type="journal" id="cre270103-cit-0037">
<string-name>
<surname>Phipps</surname>, <given-names>R. P.</given-names>
</string-name>, <string-name>
<given-names>M. A.</given-names>
<surname>Borrello</surname>
</string-name>, and <string-name>
<given-names>T. M.</given-names>
<surname>Blieden</surname>
</string-name>. <year>1997</year>. &#x0201c;<article-title>Fibroblast Heterogeneity in the Periodontium and Other Tissues</article-title>.&#x0201d; <source>Journal of Periodontal Research</source>
<volume>32</volume>, no. <issue>1 Pt 2</issue>: <fpage>159</fpage>&#x02013;<lpage>165</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-0765.1997.tb01398.x</pub-id>.<pub-id pub-id-type="pmid">9085227</pub-id>
</mixed-citation></ref><ref id="cre270103-bib-0038"><mixed-citation publication-type="journal" id="cre270103-cit-0038">
<string-name>
<surname>Plikus</surname>, <given-names>M. V.</given-names>
</string-name>, <string-name>
<given-names>X.</given-names>
<surname>Wang</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Sinha</surname>
</string-name>, et al. <year>2021</year>. &#x0201c;<article-title>Fibroblasts: Origins, Definitions, and Functions in Health and Disease</article-title>.&#x0201d; <source>Cell</source>
<volume>184</volume>, no. <issue>15</issue>: <fpage>3852</fpage>&#x02013;<lpage>3872</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2021.06.024</pub-id>.<pub-id pub-id-type="pmid">34297930</pub-id>
</mixed-citation></ref><ref id="cre270103-bib-0039"><mixed-citation publication-type="journal" id="cre270103-cit-0039">
<string-name>
<surname>Pulido&#x02010;Escribano</surname>, <given-names>V.</given-names>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Torrecillas&#x02010;Baena</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Camacho&#x02010;Cardenosa</surname>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Dorado</surname>
</string-name>, <string-name>
<given-names>M. &#x000c1;.</given-names>
<surname>G&#x000e1;lvez&#x02010;Moreno</surname>
</string-name>, and <string-name>
<given-names>A.</given-names>
<surname>Casado&#x02010;D&#x000ed;az</surname>
</string-name>. <year>2022</year>. &#x0201c;<article-title>Role of Hypoxia Preconditioning in Therapeutic Potential of Mesenchymal Stem&#x02010;Cell&#x02010;Derived Extracellular Vesicles</article-title>.&#x0201d; <source>World Journal of Stem Cells</source>
<volume>14</volume>, no. <issue>7</issue>: <fpage>453</fpage>&#x02013;<lpage>472</lpage>, July. <pub-id pub-id-type="doi">10.4252/wjsc.v14.i7.453</pub-id>.<pub-id pub-id-type="pmid">36157530</pub-id>
</mixed-citation></ref><ref id="cre270103-bib-0040"><mixed-citation publication-type="journal" id="cre270103-cit-0040">
<string-name>
<surname>Sagaradze</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<given-names>O.</given-names>
<surname>Grigorieva</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Nimiritsky</surname>
</string-name>, et al. <year>2019</year>. &#x0201c;<article-title>Conditioned Medium From Human Mesenchymal Stromal Cells: Towards the Clinical Translation</article-title>.&#x0201d; <source>International Journal of Molecular Sciences</source>
<volume>20</volume>, no. <issue>7</issue>: <elocation-id>1656</elocation-id>. <pub-id pub-id-type="doi">10.3390/ijms20071656</pub-id>.<pub-id pub-id-type="pmid">30987106</pub-id>
</mixed-citation></ref><ref id="cre270103-bib-0041"><mixed-citation publication-type="journal" id="cre270103-cit-0041">
<string-name>
<surname>Sanchooli</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Norouzian</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Ardeshirylajimi</surname>
</string-name>, et al. <year>2017</year>. &#x0201c;<article-title>Adipose Derived Stem Cells Conditioned Media in Combination With Bioceramic&#x02010;Collagen Scaffolds Improved Calvarial Bone Healing in Hypothyroid Rats</article-title>.&#x0201d; <source>Iranian Red Crescent Medical Journal</source>
<volume>19</volume>, no. <issue>5</issue>: <fpage>1</fpage>&#x02013;<lpage>12</lpage>. <pub-id pub-id-type="doi">10.5812/ircmj.45516</pub-id>.</mixed-citation></ref><ref id="cre270103-bib-0042"><mixed-citation publication-type="journal" id="cre270103-cit-0042">
<string-name>
<surname>Sanz</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Herrera</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Kebschull</surname>
</string-name>, et al. <year>2020</year>. &#x0201c;<article-title>Treatment of Stage I&#x02010;III Periodontitis &#x02013; The EFP S3 Level Clinical Practice Guideline</article-title>.&#x0201d; <source>Journal of Clinical Periodontology</source>
<volume>47</volume>, no. <issue>Suppl 22</issue>: <fpage>4</fpage>&#x02013;<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1111/jcpe.13290</pub-id>.<pub-id pub-id-type="pmid">32383274</pub-id>
</mixed-citation></ref><ref id="cre270103-bib-0044"><mixed-citation publication-type="journal" id="cre270103-cit-0044">
<string-name>
<surname>Shanbhag</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Kampleitner</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Al&#x02010;Sharabi</surname>
</string-name>, et al. <year>2023</year>. &#x0201c;<article-title>Functionalizing Collagen Membranes With MSC&#x02010;Conditioned Media Promotes Guided Bone Regeneration in Rat Calvarial Defects</article-title>.&#x0201d; [In English.] <source>Cells</source>
<volume>12</volume>, no. <issue>5</issue>: <elocation-id>767</elocation-id>. <pub-id pub-id-type="doi">10.3390/cells12050767</pub-id>.<pub-id pub-id-type="pmid">36899904</pub-id>
</mixed-citation></ref><ref id="cre270103-bib-0030"><mixed-citation publication-type="journal" id="cre270103-cit-0030">
<string-name>
<surname>Sharma</surname>, <given-names>A. R.</given-names>
</string-name>, <string-name>
<given-names>R. K.</given-names>
<surname>Jaiswal</surname>
</string-name>, and <string-name>
<given-names>S. S.</given-names>
<surname>Kamble</surname>
</string-name>, et al. <year>2023</year>. &#x0201c;<article-title>Chronic Inflammation on Gingiva&#x02010;Derived Mesenchymal Stem Cells</article-title>.&#x0201d; [In English.] <source>Bioinformation</source>
<volume>19</volume>, no. <issue>1</issue>: <fpage>138</fpage>&#x02013;<lpage>142</lpage>. <pub-id pub-id-type="doi">10.6026/97320630019138</pub-id>.<pub-id pub-id-type="pmid">37720288</pub-id>
</mixed-citation></ref><ref id="cre270103-bib-0045"><mixed-citation publication-type="journal" id="cre270103-cit-0045">
<string-name>
<surname>Shin</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Lee</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Kwon</surname>
</string-name>, et al. <year>2021</year>. &#x0201c;<article-title>Comparative Proteomic Analysis of the Mesenchymal Stem Cells Secretome From Adipose, Bone Marrow, Placenta and Wharton's Jelly</article-title>.&#x0201d; <source>International Journal of Molecular Sciences</source>
<volume>22</volume>, no. <issue>2</issue>: <elocation-id>845</elocation-id>. <pub-id pub-id-type="doi">10.3390/ijms22020845</pub-id>.<pub-id pub-id-type="pmid">33467726</pub-id>
</mixed-citation></ref><ref id="cre270103-bib-0046"><mixed-citation publication-type="journal" id="cre270103-cit-0046">
<string-name>
<surname>Sun</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<given-names>Z.</given-names>
<surname>Wang</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Liu</surname>
</string-name>, et al. <year>2022</year>. &#x0201c;<article-title>Exosomes Derived From Human Gingival Mesenchymal Stem Cells Attenuate the Inflammatory Response in Periodontal Ligament Stem Cells</article-title>.&#x0201d; [In English.] <source>Frontiers in Chemistry</source>
<volume>10</volume>: <elocation-id>863364</elocation-id>. <pub-id pub-id-type="doi">10.3389/fchem.2022.863364</pub-id>.<pub-id pub-id-type="pmid">35464198</pub-id>
</mixed-citation></ref><ref id="cre270103-bib-0047"><mixed-citation publication-type="journal" id="cre270103-cit-0047">
<string-name>
<surname>Tyanova</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Temu</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Sinitcyn</surname>
</string-name>, et al. <year>2016</year>. &#x0201c;<article-title>The Perseus Computational Platform for Comprehensive Analysis of (Prote)Omics Data</article-title>.&#x0201d; [In English.] <source>Nature Methods</source>
<volume>13</volume>, no. <issue>9</issue>: <fpage>731</fpage>&#x02013;<lpage>740</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth.3901</pub-id>.<pub-id pub-id-type="pmid">27348712</pub-id>
</mixed-citation></ref><ref id="cre270103-bib-0048"><mixed-citation publication-type="journal" id="cre270103-cit-0048">
<string-name>
<surname>Velnar</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<given-names>T.</given-names>
<surname>Bailey</surname>
</string-name>, and <string-name>
<given-names>V.</given-names>
<surname>Smrkolj</surname>
</string-name>. <year>2009</year>. &#x0201c;<article-title>The Wound Healing Process: An Overview of the Cellular and Molecular Mechanisms</article-title>.&#x0201d; <source>Journal of International Medical Research</source>
<volume>37</volume>, no. <issue>5</issue>: <fpage>1528</fpage>&#x02013;<lpage>1542</lpage>. <pub-id pub-id-type="doi">10.1177/147323000903700531</pub-id>.<pub-id pub-id-type="pmid">19930861</pub-id>
</mixed-citation></ref><ref id="cre270103-bib-0049"><mixed-citation publication-type="journal" id="cre270103-cit-0049">
<string-name>
<surname>Wang</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Cao</surname>
</string-name>, and <string-name>
<given-names>W.</given-names>
<surname>Hua</surname>
</string-name>, et al. <year>2022</year>. &#x0201c;<article-title>Mesenchymal Stem Cell&#x02010;Derived Extracellular Vesicles for Bone Defect Repair</article-title>.&#x0201d; <source>Membranes (Basel)</source>
<volume>12</volume>, no. <issue>7</issue>: <elocation-id>716</elocation-id>. <pub-id pub-id-type="doi">10.3390/membranes12070716</pub-id>.<pub-id pub-id-type="pmid">35877919</pub-id>
</mixed-citation></ref><ref id="cre270103-bib-0050"><mixed-citation publication-type="journal" id="cre270103-cit-0050">
<string-name>
<surname>Wang</surname>, <given-names>X.</given-names>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Chen</surname>
</string-name>, and <string-name>
<given-names>W.</given-names>
<surname>Tian</surname>
</string-name>. <year>2022</year>. &#x0201c;<article-title>Strategies of Cell and Cell&#x02010;Free Therapies for Periodontal Regeneration: The State of the Art</article-title>.&#x0201d; <source>Stem Cell Research &#x00026; Therapy</source>
<volume>13</volume>, no. <issue>1</issue>: <fpage>536</fpage>. <pub-id pub-id-type="doi">10.1186/s13287-022-03225-z</pub-id>.<pub-id pub-id-type="pmid">36575471</pub-id>
</mixed-citation></ref><ref id="cre270103-bib-0051"><mixed-citation publication-type="journal" id="cre270103-cit-0051">
<string-name>
<surname>Wielento</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<given-names>K. B.</given-names>
<surname>Lagosz&#x02010;Cwik</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Potempa</surname>
</string-name>, and <string-name>
<given-names>A. M.</given-names>
<surname>Grabiec</surname>
</string-name>. <year>2023</year>. &#x0201c;<article-title>The Role of Gingival Fibroblasts in the Pathogenesis of Periodontitis</article-title>.&#x0201d; <source>Journal of Dental Research</source>
<volume>102</volume>, no. <issue>5</issue>: <fpage>489</fpage>&#x02013;<lpage>496</lpage>. <pub-id pub-id-type="doi">10.1177/00220345231151921</pub-id>.<pub-id pub-id-type="pmid">36883660</pub-id>
</mixed-citation></ref><ref id="cre270103-bib-0052"><mixed-citation publication-type="journal" id="cre270103-cit-0052">
<string-name>
<surname>Yang</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Guo</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Xiao</surname>
</string-name>, and <string-name>
<given-names>Y.</given-names>
<surname>Ding</surname>
</string-name>. <year>2020</year>. &#x0201c;<article-title>Enhanced Wound Healing and Osteogenic Potential of Photodynamic Therapy on Human Gingival Fibroblasts</article-title>.&#x0201d; <source>Photodiagnosis and Photodynamic Therapy</source>
<volume>32</volume>: <elocation-id>101967</elocation-id>. <pub-id pub-id-type="doi">10.1016/j.pdpdt.2020.101967</pub-id>.<pub-id pub-id-type="pmid">32835879</pub-id>
</mixed-citation></ref><ref id="cre270103-bib-0053"><mixed-citation publication-type="journal" id="cre270103-cit-0053">
<string-name>
<surname>Yin</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Jia</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Ran</surname>
</string-name>, et al. <year>2021</year>. &#x0201c;<article-title>Exosomes Derived From Idiopathic Gingival Fibroma Fibroblasts Regulate Gingival Fibroblast Proliferation and Apoptosis</article-title>.&#x0201d; [In English.] <source>Oral Diseases</source>
<volume>27</volume>, no. <issue>7</issue>: <fpage>1789</fpage>&#x02013;<lpage>1795</lpage>. <pub-id pub-id-type="doi">10.1111/odi.13707</pub-id>.<pub-id pub-id-type="pmid">33140502</pub-id>
</mixed-citation></ref><ref id="cre270103-bib-0054"><mixed-citation publication-type="journal" id="cre270103-cit-0054">
<string-name>
<surname>Zhuang</surname>, <given-names>X.&#x02010;m</given-names>
</string-name>, and <string-name>
<given-names>B.</given-names>
<surname>Zhou</surname>
</string-name>. <year>2020</year>. &#x0201c;<article-title>Exosome Secreted by Human Gingival Fibroblasts in Radiation Therapy Inhibits Osteogenic Differentiation of Bone Mesenchymal Stem Cells by Transferring miR&#x02010;23a</article-title>.&#x0201d; <source>Biomedicine &#x00026; Pharmacotherapy = Biomedecine &#x00026; Pharmacotherapie</source>
<volume>131</volume>: <elocation-id>110672</elocation-id>. <pub-id pub-id-type="doi">10.1016/j.biopha.2020.110672</pub-id>.<pub-id pub-id-type="pmid">32889404</pub-id>
</mixed-citation></ref></ref-list></back></article>